The Open Medicinal Chemistry Journal




ISSN: 1874-1045 ― Volume 15, 2021
RESEARCH ARTICLE

Antiviral Activity of Benzotriazole Based Derivatives



Paola Corona1, Sandra Piras1, *, Roberta Ibba1, Federico Riu1, Gabriele Murineddu1, Giuseppina Sanna2, Silvia Madeddu2, Ilenia Delogu2, Roberta Loddo2, *, Antonio Carta1
1 Department of Chemistry and Pharmacy, University of Sassari, Via Muroni, 23/A, 07100 Sassari, Italy.
2 Department of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, Cittadella Universitaria, 09042, Monserrato, Italy.

Abstract

Background:

For the last thirty years, the benzotriazole scaffold has been the object of our group interest and we have already presented some results on the antiviral activity of our compounds.

Objective:

In this article, we conclude the exploration of N-(4-(R-2H-benzo[d][1,2,3]triazol-2-yl)phenyl)-4-R’-benzamides and 1-(4-(R-2H-benzo[d][1,2,3]triazol-2-yl)phenyl)-3-R’-ureas by synthesizing further modified derivatives, in order to have more elements for SARs evaluation.

Methods:

Here, we reported the synthesis and the antiviral screening results of 38 newly synthesized benzotriazole derivatives against a panel of DNA and RNA viruses. We also analyse SARs in comparing these compounds with previously published benzotriazole analogues, taking stock of the situation.

Results:

Among the newly presented derivatives, compounds 17 and 18 were the most active with EC50 6.9 and 5.5 µM, respectively against Coxsackievirus B5 (CV-B5) and 20.5 and 17.5 µM against Poliovirus (Sb-1).

Conclusion:

we can conclude that N-(4-(2H-benzo[d] [1 - 3] triazol-2-yl)phenyl-R-amide is a good chemical scaffold for the development of new antiviral molecules.

Keywords: Benzotriazole, Enteroviruses, CV-B5, Poliovirus, SARs, Antiviral.


Article Information


Identifiers and Pagination:

Year: 2020
Volume: 14
First Page: 83
Last Page: 98
Publisher Id: TOMCJ-14-83
DOI: 10.2174/1874104502014010083

Article History:

Received Date: 28/5/2020
Revision Received Date: 12/8/2020
Acceptance Date: 06/9/2020
Electronic publication date: 23/10/2020
Collection year: 2020

© 2020 Corona et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


* Address correspondence to these authors at the Department of Chemistry and Pharmacy, University of Sassari, Via Muroni 23/A, 07100, Sassari, Italy; E-mail: piras@uniss.it and Department of Biomedical Sciences, Section of Microbiology and Virology, University of Cagliari, Cittadella Universitaria, 09042, Monserrato, Italy; E-mail: rloddo@unica.it





1. INTRODUCTION

Benzotriazole and its derivatives have a great importance in the biomedical research. The chemical activities of this scaffold are manifold; it can be used as intermediate [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
], leaving group [4Katritzky, A.R.; Rogovoy, B.V. Benzotriazole: An ideal synthetic auxiliary. Chemistry, 2003, 9(19), 4586-4593.
[http://dx.doi.org/10.1002/chem.200304990] [PMID: 14566863]
], or inserted into other chemical structures [5Wang, X.; Liu, Y. Y. Z. Elimination of benzotriazolyl group in n-(α-benzotriazol-1-ylalkyl)amides and n-(α-benzotriazol-1-ylalkyl)sulfonamides: Their self-coupling and cross-coupling reactions with carbonyl compounds. Tetrahedron, 2003, 59, 8257-8263.
[http://dx.doi.org/10.1016/j.tet.2003.08.039]
]. The antimicrobial activity of benzotriazole derivatives has been extensively investigated since the late 1980s and several authors disclosed the biological evaluation of imidazole derivatives and benzotriazole analogues as antibacterial, antimycotic, antitubercular, and antiviral agents [6Briguglio, I.; Piras, S.; Corona, P.; Gavini, E.; Nieddu, M.; Boatto, G.; Carta, A. Benzotriazole: An overview on its versatile biological behavior. Eur. J. Med. Chem., 2015, 97(1), 612-648.
[http://dx.doi.org/10.1016/j.ejmech.2014.09.089] [PMID: 25293580]
]. The number of viruses and the viral infections are continuously increasing. Poverty, rapid urbanization, evolving human migration patterns, re-emerging viruses, all contribute to the expanding impact of viral diseases. Environmental variations and derangements caused by changes in the climate and alterations to the ecology caused by man have increased the possibility for new contacts between the various factors involved, giving rise conditions for the emergence of new infections. This is reflected by the recent emergence of viral outbreaks caused by West Nile virus (WNV), severe acute respiratory syndrome (SARS) virus, Enterovirus A71 and D68, influenza virus, measles virus (MV) [7Christou, L. The global burden of bacterial and viral zoonotic infections. Clinical Microbiology and Infection, 2011, 17(3), 326-30.-9Grais, R. F.; Strebel, P.; Mala, P.; Watson, J.; Nandy, R.; Gayer, M. Measles vaccination in humanitarian emergencies: A review of recent practice. Conflict Health. BioMed Central, 2011, 21.] and coronavirus (SARS-CoV-2) nowadays [10 Coronavirus, Avaliable at: https://www.who.int/health-topics/corona virus#tab=tab_1]. While vaccine efforts have been proven successful for preventing and eradicating some viral infections, for many viruses there is not any vaccine, efficacious drugs for prophylaxis or therapeutic treatments available. Thus, more attempts in developing antiviral therapies are needed to protect public health against a range of important viral pathogens. Progress has been made recently on azole derivatives as antibacterial, antifungal, antitubercular and antiviral agents, including mono-nitrogen azoles (oxazoles, thiazoles and carbazoles), bis-nitrogen azoles (imidazoles, pyrazoles and benzimidazoles) and tri-nitrogen azoles (triazoles and benzotriazoles) [11Zhang, H-Z.; Gan, L-L.; Wang, H.; Zhou, C-H. New progress in azole compounds as antimicrobial agents. Mini Rev. Med. Chem., 2017, 17(2), 122-166.
[http://dx.doi.org/10.2174/1389557516666160630120725] [PMID: 27484625]
-14Sanna, G.; Madeddu, S.; Giliberti, G.; Piras, S.; Struga, M.; Wrzosek, M.; Kubiak-Tomaszewska, G.; Koziol, A.E.; Savchenko, O.; Lis, T.; Stefanska, J.; Tomaszewski, P.; Skrzycki, M.; Szulczyk, D. Synthesis and biological evaluation of novel indole-derived thioureas. Molecules, 2018, 23(10), 2554.
[http://dx.doi.org/10.3390/molecules23102554] [PMID: 30301264]
]. Starting from these considerations and among a multi-annual antiviral research program, in the last years, we described the chemical characterization and antiviral activity of several series of azole derivatives as benzimidazole, benzotriazoles [15Carta, A.; Loriga, G.; Piras, S.; Paglietti, G.; Ferrone, M.; Fermeglia, M.; Pricl, S.; La Colla, P.; Secci, B.; Collu, G.; Loddo, R. Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides. Med. Chem., 2006, 2(6), 577-589.
[http://dx.doi.org/10.2174/1573406410602060577] [PMID: 17105439]
-17Piras, S.; Corona, P.; Ibba, R.; Riu, F.; Murineddu, G.; Sanna, G.; Madeddu, S.; Delogu, I.; Loddo, R.; Carta, A. Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)- 1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas. Med. Chem., 2020, 16(5), 677-688.
[http://dx.doi.org/10.2174/1573406416666191226142744] [PMID: 31878859]
], and a large series of both benzimidazole and benzotriazole derivatives condensed with a pyridine ring [18Briguglio, I.; Loddo, R.; Laurini, E.; Fermeglia, M.; Piras, S.; Corona, P.; Giunchedi, P.; Gavini, E.; Sanna, G.; Giliberti, G.; Ibba, C.; Farci, P.; La Colla, P.; Pricl, S.; Carta, A. Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives. Eur. J. Med. Chem., 2015, 105, 63-79.
[http://dx.doi.org/10.1016/j.ejmech.2015.10.002] [PMID: 26479028]
, 19Carta, A.; Briguglio, I.; Piras, S.; Corona, P.; Ibba, R.; Laurini, E.; Fermeglia, M.; Pricl, S.; Desideri, N.; Atzori, E.M.M.; La Colla, P.; Collu, G.; Delogu, I.; Loddo, R. A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems. Eur. J. Med. Chem., 2016, 117, 321-334.
[http://dx.doi.org/10.1016/j.ejmech.2016.03.080] [PMID: 27161176]
]. Among these azoles, benzotriazoles derivatives bearing one or two chlorine atoms on the benzene moiety of benzotriazole, in positions 5 and 6, have proved to be of particular interest. From an extensive screening against both RNA and DNA viruses, these derivates were found to be active against BVDV and hRSV [16Piras, S.; Sanna, G.; Carta, A.; Corona, P.; Ibba, R.; Loddo, R.; Madeddu, S.; Caria, P.; Aulic, S.; Laurini, E.; Fermeglia, M.; Pricl, S. Dichloro-phenyl-benzotriazoles: A new selective class of human respiratory syncytial virus entry inhibitors. Front Chem., 2019, 7(MAR), 247.
[http://dx.doi.org/10.3389/fchem.2019.00247] [PMID: 31041309]
], while the elimination of a chlorine atom on the same scaffold resulted in the loss of activity on all viral strains tested [16Piras, S.; Sanna, G.; Carta, A.; Corona, P.; Ibba, R.; Loddo, R.; Madeddu, S.; Caria, P.; Aulic, S.; Laurini, E.; Fermeglia, M.; Pricl, S. Dichloro-phenyl-benzotriazoles: A new selective class of human respiratory syncytial virus entry inhibitors. Front Chem., 2019, 7(MAR), 247.
[http://dx.doi.org/10.3389/fchem.2019.00247] [PMID: 31041309]
].

This project aimed to evaluate how changes on the benzotriazole scaffold, or in the amide portion, could affect the antiviral activity of previously reported derivatives. Starting from compounds with general structure depicted in Fig. (1)., which turned out active towards Coxsackieviruses, BVDV and hRSV [16Piras, S.; Sanna, G.; Carta, A.; Corona, P.; Ibba, R.; Loddo, R.; Madeddu, S.; Caria, P.; Aulic, S.; Laurini, E.; Fermeglia, M.; Pricl, S. Dichloro-phenyl-benzotriazoles: A new selective class of human respiratory syncytial virus entry inhibitors. Front Chem., 2019, 7(MAR), 247.
[http://dx.doi.org/10.3389/fchem.2019.00247] [PMID: 31041309]
], we designed and synthesised a series of derivatives 4-7c, 8a,b,c-15a,b,c, 16c-26c (underline-labelled in Fig. (2). and compared their antiviral activity with previously published compounds (4a,b-26a,b, 16d-18d, 20d-26d; not underline-labelled in Fig. (2). describing Structure-activity Relationships (SARs).

In all these derivatives, we evaluated the role of the substitution of the benzotriazole ring with hydrogen, fluorine, chlorine atoms, or methyl groups. Similarly, the replacement of the amide moiety with an ureidic function on all series of new benzotriazole derivatives was assessed, since previously synthesised similar compounds (16a,b-26a,b, 16d-18d, 20d-26d) had shown interesting antiviral activity [16Piras, S.; Sanna, G.; Carta, A.; Corona, P.; Ibba, R.; Loddo, R.; Madeddu, S.; Caria, P.; Aulic, S.; Laurini, E.; Fermeglia, M.; Pricl, S. Dichloro-phenyl-benzotriazoles: A new selective class of human respiratory syncytial virus entry inhibitors. Front Chem., 2019, 7(MAR), 247.
[http://dx.doi.org/10.3389/fchem.2019.00247] [PMID: 31041309]
, 17Piras, S.; Corona, P.; Ibba, R.; Riu, F.; Murineddu, G.; Sanna, G.; Madeddu, S.; Delogu, I.; Loddo, R.; Carta, A. Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)- 1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas. Med. Chem., 2020, 16(5), 677-688.
[http://dx.doi.org/10.2174/1573406416666191226142744] [PMID: 31878859]
], modification of the chemical scaffold are outlined in Fig. (3).

Fig. (1)
General structure of previously reported compounds.


Fig. (2)
Panel of all molecules analysed for SARs.


Fig. (3)
Chemical modification on benzotriazole scaffold to obtain intended derivatives.


All newly prepared derivatives were assayed against representatives positive- and negative- sense single-stranded RNA, double-stranded RNA viruses and DNA viruses. In order to establish whether tested compounds worked selectively as antiviral agents, their cytotoxicity against cell monolayers (in stationary growth) analogous to those supporting the replication of the above viruses, but left uninfected, was evaluated in parallel with their antiviral activity.

2. MATERIALS AND METHODS

2.1. Synthetic Methods

Melting points (m.p.) were carried out with a Köfler hot stage or Digital Electrothermal melting point apparatus. Nuclear magnetic resonance (1H-NMR and 13C-NMR) spectra were determined in CDCl3 or DMSO-d6 and recorded with a Bruker Avance III 400 NanoBay. Chemical shifts are reported in parts per million (ppm) downfield from tetramethylsilane (TMS) used as internal standard. Splitting patterns are designated as follows: s, singlet; d, doublet; t, triplet; q, quadruplet; quin, quintet; sext, sextet; sept, septet; m, multiplet; br s, broad singlet; dd, double doublet. Mass spectra (MS) were performed on the combined Liquid Chromatograph-Agilent 1100 series Mass Selective Detector (MSD). Analytical thin-layer Chromatography (TLC) was performed on Merck silica gel F-254 plates. Pure compounds showed a single spot in TLC. For flash chromatography, Merck silica gel 60 was used with a particle size of 0.040-0.063mm (230-400 mesh ASTM). Elemental analyses were performed on a Perkin-Elmer 2400 instrument and the results were within ±0.4% of theoretical values.

2.2. Starting Material and Known Intermediates

Anhydrides, benzoyl derivatives, 1-chloro-4-nitrobenzene, and inorganic reagent were commercially available. The intermediate 3-fluorobenzene-1,2-diamine, common to the whole series, was prepared according to the procedures described in the literature [20Kirk, K.L.; Cohen, L.A. The synthesis of some fluoronitrobenzimidazoles and their reactivities toward peptide nucleophiles. J. Org. Chem., 1969, 34(2), 384-389.
[http://dx.doi.org/10.1021/jo01254a027] [PMID: 5786166]
, 21Liedholm, B.; Nyberg, I.; Svanholm, U.; Duffield, A.M.; Balaban, A.T.; Craig, J.C. Copper(I) catalysed replacement of bromine by chloride ion in halonitrobenzenes. Acta Chem. Scand., 1969, 23, 3175-3186.
[http://dx.doi.org/10.3891/acta.chem.scand.23-3175]
] . Details of the synthesis of each compound are provided as follows.

2.3. Cells and Viruses

Cell lines were purchased from American Type Culture Collection (ATCC). Cell lines supporting the multiplication of virus were following: Monkey kidney (Vero-76) [ATCC CRL 1587 Cercopithecus Aethiops]. Viruses were purchased from the American Type Culture Collection (ATCC). Viruses representative of positive-sense, single-stranded RNAs (ssRNA+) were: Picornaviridae: human enterovirus B [coxsackie type B5 (CV-B5), strain Faulkner (ATCC VR-185)], and human enterovirus C [poliovirus type-1 (Sb-1), Sabin strain Chat (ATCC VR-1562)]. Cell cultures were checked periodically for the absence of mycoplasma contamination with MycoTect Kit (Gibco). Viruses were maintained in our laboratory and propagated in appropriate cell lines. The viruses were stored in small aliquots at -80 °C until use.

2.4. Cytotoxicity Assays

Vero-76 cells were seeded in 96-well plates at an initial density of 5x105 cells/mL, in Dulbecco’s Modified Eagle Medium (D-MEM) with L-glutamine and 25 mg/L kanamycin, supplemented with 10% FBS. Cell cultures were then incubated at 37 °C in a humidified, 5% CO2 atmosphere, in the absence or presence of serial dilutions of test compounds. The test medium used for the cytotoxic assay as well as for antiviral assay contained 1% of the appropriate serum. Cell viability was determined after 72 hrs at 37 °C by the MTT method [22Pauwels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdewijn, P.; Desmyter, J.; De Clercq, E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods, 1988, 20(4), 309-321.
[http://dx.doi.org/10.1016/0166-0934(88)90134-6] [PMID: 2460479]
].

2.5. Antiviral Assay

Compound’s activity against CV-B5 and Sb-1 was determined by plaque reduction assays in infected cell monolayers. Briefly, a monolayer of Vero-76 cells was grown overnight on 24-well plate. The cells were then infected for 2 hrs with 250 μL of proper virus dilutions to give 50-100 PFU/well. Following the removal of unadsorbed virus, 500 μL of the medium [D-MEM with L-glutamine and 4500 mg/L D-glucose, supplemented with 1% inactivated FBS] containing 0.75% methylcellulose, with serial dilutions of test compounds, were added. The overlayed medium was also added to not treated wells as non-infection controls. Cultures were incubated at 37 °C for 2 (Sb-1), 3 (CV-B5) days and then fixed with PBS containing 50% ethanol and 0.8% crystal violet, washed and air-dried. Plaques in the control (no inhibitor) and experimental wells were then counted.

2.6. Linear Regression Analysis

The extent of cell growth/viability and viral multiplication, at each drug concentration tested, were expressed as a percentage of untreated controls. Concentrations resulting in 50% inhibition (CC50 or EC50) were determined by linear regression analysis.

2.7. Experimental Section

2.7.1. General procedure for the preparation of 7-fluoro-1-(4-nitrophenyl)-1H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazole (1), 4-fluoro-2-(4-nitrophenyl)-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazole (2) and 4-fluoro-1-(4-nitrophenyl)-1H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazole (3).

To a solution of 2 g (14.6 mmol) of 4-fluoro-1H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazole in 14 mL of dimethyl acetamide (DMA), 1-chloro-4-nitrobenzene (2.3 g, 14.6 mmol) and Cs2CO3 (9.51 g, 29.2 mmol) were added. The mixture was stirred at 75°C for 36 h. The precipitate was filtered by washing a little amount of water to remove Cs2CO3, and the filtrate was poured on ice. The obtained light-yellow precipitate was the mixture of the three isomers and was filtered under vacuum. The three isomers were separated by flash chromatography using petroleum ether/ethyl acetate in different ratio as eluting system. The assignment of the correct structure to the isomers (1), (2) and (3) was achieved from NOESY experiment as discussed in paragraph 2.1 of this article.

2.7.1.1. 7-fluoro-1-(4-nitrophenyl)-1H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazole (1)

Compound (1) was purified by silica gel column chromatography eluting with a 9:1 mixture of petroleum ether/ethyl acetate. Light-yellow solid, m.p.: 188-191°C.Yield, 1%. TLC (petroleum ether/ethyl acetate 9:1): Rf 0.22. 1H-NMR (DMSO, 400 MHz) δ: 8.51 (2H, d, J = 8.4 Hz, H-3’,5’), 8.13 (2H, d, J = 8.4 Hz, H-2’,6’), 8.091 (1H, d, J = 8 Hz, H-4), 7.59-7.55 (2H, m, H-5,6). 13C-NMR (CDCl3, 100 MHz) δ: 149.5 (C, C-7), 148.4 (C, C-3a), 147.3 (C, C-7a), 145.7 (C, C-4’), 140.9 (C, C-1’), 126.0 (CH, C-5), 125.49 (CH, C-2’, C-6’), 124.91 (CH, C-3’, 5’), 116.20 (CH, C-4), 114.23 (CH, C-6). LC/MS: m/z 259 (M+H). Anal. Calcd. (%) C12H7FN4O2: C, 55.82; H, 2.73; N, 21.70. Found: C, 55.94; H, 2.77; N, 21.84.

2.7.1.2. 4-fluoro-2-(4-nitrophenyl)-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazole (2)

Compound (2) was purified by silica gel column chromatography eluting with a 9.8:0.2 mixture of petroleum ether/ethyl acetate. Light-yellow solid, m.p.:234-237°C. Yield, 37%. TLC (petroleum ether/ethyl acetate 9:1): Rf 0.46. 1H-NMR (DMSO, 400 MHz) δ: 8.59 (2H, d, J = 9.2 Hz, H-2̍,6̍), 8.51 (2H, d, J = 9.2 Hz, H-3̍,5̍), 7.93 (1H, d, J = 8.8 Hz, H-7), 7.60-7.54 (1H, m, H-6), 7.41 (1H, dd, J = 7.2 and 10.8 Hz, H-5). 13C-NMR (DMSO, 100 MHz) δ: 152.8 (C, C-4). 147.5 (C, C-7a), 147.3 (C, C-1’), 136.2 (C, C-3a), 134.1 (C, C-4’), 125.6 (CH, C-6), 124.4 (CH, C-7), 121.5 (CH, C-2’, C-6’), 115.1 (CH, C-3’, 5’), 111.6 (CH, C-5). LC/MS: m/z 259 (M+H). Anal. Calcd. (%) C12H7FN4O2: C, 55.82; H, 2.73; N, 21.70. Found: C, 55.92; H, 2.78; N, 21.85.

2.7.1.3. 4-fluoro-1-(4-nitrophenyl)-1H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazole (3)

Compound (3) was purified by silica gel column chromatography eluting with a 8.5:1.5 mixture of petroleum ether/ethyl acetate. Light-yellow solid, m.p.: 233-236°C. Yield, 2%. TLC (petroleum ether/ethyl acetate 9:1): Rf 0.16. 1H-NMR (DMSO, 400 MHz) δ: 8.52 (2H, d, J = 8.8 Hz, H-3̍, 5̍), 8.25 (2H, d, J = 8.8 Hz, H-2̍, 6̍), 7.92 (1H, d, J = 8.4 Hz, H-7), 7,61 (1H, m, H-6), 7,44 (1H, t, H-5). 13C-NMR (DMSO, 100 MHz) δ: 152.4 (C, C-4), 146.9 (C, C-7a), 140.8 (C, C-1’), 136.0 (C, C-3a), 134.4 (C, C-4’), 125.6 (CH, C-6), 123.4 (CH, C-2’, C-6’), 110.0 (CH, C-7), 109.9 (CH, C-3’, 5’), 107.9 (CH, C-5,). LC/MS: m/z 259 (M+H). Anal. Calcd. (%) C12H7FN4O2: C, 55.82; H, 2.73; N, 21.70. Found: C, 55.90; H, 2.80; N, 21.83.

2.7.2. 4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)aniline (4c)

Compound (4c) was obtained by dissolving 2g of derivative 2 (7.74 mmol) in 269 mL of ethanol followed by the addition of 10% Palladium on activated charcoal and hydrazine hydrate (3.47 g, 108.08 mmol). The mixture was heated at 110°C for 20 h, after cooling the catalyst was filtered and washed with ethanol, the filtrate was evaporated under reduced pressure. The crude product was purified by flash chromatography using petroleum ether/ethyl acetate 7:3 as eluting system. 933 mg of 4c was obtained as a light-yellow solid, m.p. 167-169°C (from EtOH). Yield: 53%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.41. 1H-NMR (CDCl3, 400 MHz) δ: 8.05 (2H, d, J= 7.6 Hz, H-2̍, 6̍), 7.62 (1H, d, J= 8.4 Hz, H-7), 7.26-7.21 (1H, m, H-6), 6.96 (1H, t, H-5), 6.73 (2H, d, J= 7.6 Hz, H-3̍, 5̍), 3.89 (2H, br s, NH2). 13C-NMR (CDCl3, 100 MHz) δ: 152.5 (C, C-4), 147.8 (C, C-7a), 147.7 (C, C-1’), 135.9 (C, C-3a), 131.8 (C, C-4’), 126.5 (CH, C-6), 122.2 (CH, C-3’, C-5’), 115.0 (CH, C-2’, C-6’), 114.0 (CH, C-7), 109.8 (CH, C-5). LC/MS: m/z 229 (M+H). Anal. Calcd. (%) C12H9FN4: C, 63.15; H, 3.97; N, 24.55. Found: C, 63.24; H, 4.06; N, 24.65.

2.7.3. General procedure for the preparation of N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)amide derivatives (5c-7c).

To 4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)aniline (4c) (200 mg, 0.87 mmol) was added an excess (26.1 mmol) of either required anhydride (acetic anhydride, propionic anhydride and butyric anhydride). The resulting mixture was stirred at 100°C for different times as reported below, then it was cooled to room temperature and crushed ice was added. The solid obtained in each reaction was filtered under vacuum. Purification by flash chromatography using as eluting system, a mixture of petroleum ether/ethyl acetate in different ratios as reported below, furnished the amide derivatives 5c-7c.

2.7.3.1. 1N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl) phenyl) acetamide (5c)

Compound (5c) was obtained as described in the general procedure starting from 4c and acetic anhydride for 6h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 191-194°C (from EtOH). Yield, 28%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.45. 1H-NMR (CDCl3, 400 MHz) δ: 10.13 (1H, br s, NH), 8.52 (2H, d, J= 8.4 Hz, H-3̍,5̍), 7.65 (1H, d, J= 8.8 Hz, H-7), 7.38 (2H, d, J= 8.8 Hz, H-2̍,6̍), 7.40-7.27 (1H, m, H-6), 7.09 (1H, t, H-5), 2.35 (3H, s, CH3). 13C-NMR (CDCl3, 100 MHz) δ: 172.6 (C, CO), 152.6 (C, C-4), 147.6 (C, C-7a), 140.2 (C, C-1’), 140.1 (C, C-4’), 136.7 (C, C-3a), 131.0 (CH, C-3’, C-5’), 127. (CH, C-6), 122.0 (CH, C-2’, C-6’), 114.6 (CH, C-7), 110.7 (CH, C-5), 25.8 (CH3). LC/MS: m/z 271 (M+H). Anal. Calcd. (%) C14H11FN4O: C, 62.22; H, 4.10; N, 20.73. Found: C, 62.33; H, 4.15; N, 20.80.

2.7.3.2. N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl) phenyl) propionamide (6c)

Compound (6c) was obtained as described in the general procedure starting from 4c and propionic anhydride for 72h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Ocra yellow solid, m.p.: 179-182°C (from EtOH). Yield, 26%. TLC (petroleum ether/ethyl acetate 6:4): Rf 0.51. 1H-NMR (CDCl3, 400 MHz) δ: 8.319 (2H, d, J= 8.8 Hz, H-3̍,5̍), 7.76 (1H, d, J= 8.4 Hz, H-7), 7.70 (2H, d, J= 8.8 Hz, H-2̍,6̍), 7.48 (1H, br s, NH), 7.36-7.26 (1H, m, H-6), 7.07-7.05 (1H, t, H-5), 2.45 (2H, d, CH2), 1.28 (3H, t, CH3). 13C-NMR (CDCl3, 100 MHz) δ: 172.2 (C, CO), 152.5 (C, C-4), 147.4 (C, C-7a), 139.1 (C, C-1’), 136.2 (C, C-4’), 135.9 (C, C-3a), 127.0 (CH, C-6), 121.4 (CH, C-3’, C-5’), 118.2 (CH, C-2’, C-6’), 114.3 (CH, C-7), 110.2 (CH, C-5), 30.8 (CH2, CH2CH3), 9.55 (CH3, CH2CH3). LC/MS: m/z 285 (M+H). Anal. Calcd. (%) C15H13FN4O: C, 63.37; H, 4.61; N, 19.71. Found: C, 64.07; H, 4.69; N, 19.75.

2.7.3.3. N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl) phenyl) butyramide (7c)

Compound (7c) was obtained as described in the general procedure starting from 4c and butyric anhydride for 120h. The crude product was purified by silica gel column chromatography eluting with a 9:1 mixture of petroleum ether/ethyl acetate. Wight solid, m.p.: 208-209°C (from EtOH). Yield, 31%. TLC (petroleum ether/ethyl acetate 8:2): Rf 0.48. 1H-NMR (DMSO, 400 MHz) δ: 10.25 (1H, br s, NH), 8.26 (2H, d, J = 8.8 Hz, H-3̍,5̍), 7.89 (2H, d, J = 8.8 Hz, H-2̍,6̍), 7.88 (1H, d, J = 8.0 Hz, H-7), 7.52-7.47 (1H, m, H-6), 7.35-7.30 (1H, m, H-5), 2.35 (2H, t, CH2), 1.65 (2H, sext., CH2), 0.94 (3H, t, CH3). 13C-NMR (DMSO, 100 MHz) δ: 171.8 (C, CO), 151.4 (C, C-4), 146.8 (C, C-7a), 140.5 (C, C-1’), 135.2 (C, C-3a), 134.2 (C, C-4’), 127.6 (CH, C-6), 120.9 (CH, C-3’, C-5’), 119.7 (CH, C-2’, C-6’), 112.6 (CH, C-7), 110.7 (CH, C-5), 18.4 (CH2, CH2-CH2CH3), 13.5 (CH3, CH2-CH2-CH3). LC/MS: m/z 299 (M+H). Anal. Calcd. (%) C16H15FN4O: C, 64.42; H, 5.07; N, 18.78. Found: C, 64.51; H, 4.75; N, 19.82.

2.7.4. General procedure for the preparation of N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)benzamide derivatives (8a,b,c-15a,b,c).

The respective amines 4a-c (166 mmol) were solubilized in 8-10 ml of DMF (compounds a,b) or DMA (compounds c) and an equimolar amount (compounds c) or an equimolar amount with 20% in excess (compounds a,b) of the required benzoyl chloride derivatives was added. The solution was stirred at 80°C for different times as reported below, then it was cooled to room temperature and crushed ice was added. The reaction products were solid or a gummy oil; The solid obtained was filtered under vacuum, while the gummy oil was treated with ether. Purification by flash chromatography using as eluting system, a mixture of petroleum ether/ethyl acetate in different ratios as reported below, furnished the benzamide derivatives 8a,b,c-15a,b,c.

2.7.4.1. N-(4-(2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl) phenyl) -4-methylbenzamide (8a)

Compound (8a) was obtained as described in the general procedure starting from 4a and 4-methylbenzoyl chloride for 24h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 266-268°C (from EtOH). Yield, 80%. TLC (petroleum ether/ethyl acetate 1:1): Rf 0.90. 1H-NMR (DMSO, 400 MHz) δ: 10.49 (1H, s, NHCO), 8.32 (2H, d, J=8.4 Hz, H-2’, 6’), 8.09 (2H, d, J= 8.4 Hz, H-3’, 5’), 8.05-8.00 (2H, m, H-4, 7), 7.92 (2H, d, J= 7.6 Hz, H-2”, 6”), 7.53-7.50 (2H, m, H-5, 6), 7.37 (2H, d, J= 7.6 Hz, H-3”, 5”). 13C-NMR (DMSO, 100 MHz) δ: 165.6 (C, CO), 144.3 (C, C-4”), 141.9 (C, C-3a, C-7a), 140.4 (C, C-4’), 134.9 (C, C-1’), 131.7 (C, C-1”), 128.9 (CH, C-3”, C-5”), 127.8 (CH, C-2”, C-6”), 127.4 (CH, C-5, C-6), 120.9 (CH, C-2’, C-6’), 120.7 (CH, C-3’, C-5’), 118.0 (CH, C-4, C-7), 21.0 (CH3). LC/MS: m/z: 329 (M+H). Anal. Calcd (%) C20H16N4O: C, 73.15; H; 4.91; N, 17.06. Found: C, 73.41; H, 4.98; N, 16.91.

2.7.4.2. N-(4-(2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)-4-methoxy benzamide (9a)

Compound (9a) was obtained as described in the general procedure starting from 4a and 4-methoxybenzoyl chloride for 48h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 217-218°C (from EtOH). Yield, 90%. TLC (petroleum ether/ethyl acetate 1:1): Rf 0.81. 1H-NMR (DMSO, 400MHz) δ: 10.42 (1H, s, NHCO), 8.31 (2H, d, J= 8.4 Hz, H-2”, 6”), 8.08 (2H, d, J= 8.0 Hz, H-3”, 5”), 8.18-7.98 (4H, m, H-2’, 6’, 3’, 5’), 7.53-7.49 (2H, m, H-4, 7), 7.15-7.03 (2H, m, H-5, 6). 13C-NMR (DMSO, 100 MHz) δ: 165.1 (C, CO), 162.1 (C, O-C), 144.3 (C, C-3a, C-7a), 140.5 (C, C-4’), 134.8 (C, C-1’), 129.7 (CH, C-2”, C-6”), 127.4 (CH, C-5, C-6), 126.6 (C, C-1”), 120.8 (CH, C-2’, C-6’), 120.7 (CH, C-3’, C-5’), 118.1 (CH, C-4, C-7), 113.7 (CH, C-3”, C-5”), 55.4 (OCH3). LC/MS: m/z: 345 (M+H). Anal. Calcd (%) C20H16N4O2: C, 69.76; H, 4.68; N, 16.27. Found: C, 69.41; H, 4.43; N, 16.50.

2.7.4.3. N-(4-(2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl) phenyl)-3,4,5-trimethoxybenzamide (10a)

Compound (10a) was obtained as described in the general procedure starting from 4a and 3,4,5-trimethoxybenzoyl chloride for 2 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 217-229°C (from EtOH). Yield, 30%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.29. 1H NMR (DMSO, 400 MHz) δ: 10.44 (1H, s, NHCO), 8.34 (2H, d, J=8.4 Hz, H-2’, 6’), 8.04-8.00 (4H, m, H-4, 7, 3’, 5’), 7.53-7.50 (2H, m, H-5, 6), 7.33-7.28 (2H, m, H-2”, 6”). 13C-NMR (DMSO, 100 MHz) δ: 165.2 (C, CO), 152.6 (C, C-3”, C-5”), 144.4 (C, C-3a, C-7a), 140.4 (C, C-4”), 135.0 (C, C-1”), 129.7 (C, C-1’, C-4’), 127.5 (CH, C-5, C-6), 121.2 (CH, C-2’, C-6’), 120.7 (CH, C-3’, C-5’), 118.0 (CH, C-4, C-7), 105.4 (CH, C-2”, C-6”), 60.1 (OCH3-C4”), 56.1 (OCH3-C3”, OCH3-C5”). LC/MS: m/z: 405 (M+H). Anal. Calcd (%) C22H20N4O4: C, 65.34; H, 4.98; N, 13.85. Found: C, 64.98; H, 4.63; N, 14.20.

2.7.4.4. N-(4-(2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl) phenyl) -4-chlorobenzamide (11a)

Compound (11a) was obtained as described in the general procedure starting from 4a and 4-chlorobenzoyl chloride for 2 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 280-281°C (from EtOH). Yield, 68%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.83. 1H-NMR (DMSO, 400 MHz) δ: 10.64 (1H, s, NHCO), 8.33 (2H, d, J= 8.4 Hz, H-2’, 6’), 8.08 (2H, d, J= 8.8 Hz, H-2”, 6”), 8.08-8.00 (4H, m, H-3’, 5’, 3”, 5”), 7.69-7.63 (2H, m, H-4, 7), 7.57-7.50 (2H, m, H-5, 6). 13C-NMR (DMSO, 100 MHz) δ: 164.7 (C, CO), 144.4 (C, C-3a, C-7a), 140.0 (C, C-4”), 136.6 (C, C-4’), 135.1 (C, C-1’), 133.3 (C, C-1”), 129.7 (CH, C-2”, C-6”), 128.5 (CH, C-3”, C-5”), 127.5 (CH, C-5, C-6), 121.0 (CH, C-2’, C-6’), 120.7 (CH, C-3’, C-5’), 118.0 (CH, C-4, C-7). LC/MS: m/z: 349 (M+H). Anal. Calcd (%) C19H13ClN4O: C, 65.43; H, 3.76; N, 16.06. Found: C, 65.66; H, 4.04; N, 16.00.

2.7.4.5. N-(4-(2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl) phenyl) -4-bromobenzamide (12a)

Compound (12a) was obtained as described in the general procedure starting from 4a and 4-bromobenzoyl chloride for 2 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 248-249°C (from EtOH). Yield, 79%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.72. 1H-NMR (DMSO, 400 MHz) δ: 10.64 (1H, s, NHCO), 8.33 (2H, d, J= 8.4 Hz, H-2’, 6’), 8.07 (2H, d, J= 8.4 Hz, H-3’, 5’), 8.03-8.01 (2H, m, H-4, 7), 7.96 (2H, d, J= 8.0 Hz, H-2”, 6”), 7.79 (2H, d, J= 8.4 Hz, H-3”, 5”), 7.53-7.49 (2H, m, H-5, 6). 13C-NMR (DMSO, 100 MHz) δ: 164.8 (C, CO), 144.4 (C, C-3a, C-7a), 140.0 (C, C-4’), 135.1 (C, C-1’), 133.7 (C, C-1”), 131.5 (CH, C-3”, C-5”), 129.9 (CH, C-2”, C-6”), 127.5 (CH, C-5, C-6), 125.6 (C, C-4”), 121.0 (CH, C-2’, C-6’), 120.8 (CH, C-3’, C-5’), 118.1 (CH, C-4, C-7). LC/MS: m/z: 395 (M+H). Anal. Calcd (%) C19H13BrN4O: C, 58.03; H, 3.33; N, 14.25. Found: C, 58.23; H, 3.54; N, 14.00.

2.7.4.6. N-(4-(2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-(trifluoromethyl)benzamide (13a)

Compound (13a) was obtained as described in the general procedure starting from 4a and 4-trifluorobenzoyl chloride for 2 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 277-278°C (from EtOH). Yield, 72%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.79. 1H-NMR (DMSO, 400 MHz) δ: 10.79 (1H, s, NHCO), 8.35 (2H, d, J= 8.8 Hz, H-2’, 6’), 8.20 (2H, d, J= 7.6 Hz, H-2”, 6”), 8.09 (2H, d, J= 8.4 Hz, H-3’, 5’), 8.03-8.00 (2H, m, H-4, 7), 7.96 (2H, d, J= 8.0 Hz, H-3”, 5”), 7.54-7.50 (2H, m, H-5, 6). 13C-NMR (DMSO, 100 MHz) δ: 164.6 (C, CO), 144.4 (C, C-3a, C-7a), 139.9 (C, C-4’, C-1”), 138.4 (C, C-1’), 135.3 (C, C-4”), 131.5 (C, CF3), 128.7 (CH, C-2”, C-6”), 127.5 (CH, C-5, C-6), 125.4 (CH, C-3”, C-5”), 121.1 (CH, C-2’, C-6’), 120.8 (CH, C-3’, C-5’), 118.1 (CH, C-4, C-7). LC/MS: m/z: 383 (M+H). Anal. Calcd (%) C20H13F3N4O: C, 62.83; H, 3.43; N, 14.65. Found: C, 62.52; H, 3.23; N, 14.86.

2.7.4.7. N-(4-(2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-cyanobenzamide (14a)

Compound (14a) was obtained as described in the general procedure starting from 4a and 4-cyanobenzoyl chloride for 48h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 243-245°C (from EtOH). Yield, 22%. TLC (petroleum ether/ethyl acetate 75:25): Rf 0.13. 1H-NMR (DMSO, 400 MHz) δ: 10.59 (1H, s, NHCO), 8.40 (2H, d, J= 13.6 Hz, H-4, 7), 8.34 (2H, d, J= 8.4 Hz, H-2’, 6’), 8.14-8.06 (3H, m, H-5, 2”, 6”), 7.95 (2H, d, J= 20.4 Hz, H-3’, 5’), 7.58-7.51 (3H, m, H-6, 3”, 5”). 13C-NMR (DMSO, 100 MHz) δ: 165.0 (C, CO), 145.0 (C, C-3a, C-7a), 138.9 (C, C-1”), 137.7 (C, C-4’), 134.9 (C, C-1’), 132.2 (CH, C-3”, C-5”), 128.7 (CH, C-2”, C-6”), 126.9 (CH, C-5, C-6), 121.1 (CH, C-2’, C-6’), 120.9 (CH, C-3’, C-5’), 120.2 (CH, C-4, C-7), 118.4 (C, CN), 116.6 (C, C-4”). LC/MS: m/z: 340 (M+H). Anal. Calcd (%) C20H13N5O: C, 70.79; H, 3.86; N, 20.64. Found C, 70.49; H, 3.52; N, 20.74.

2.7.4.8. N-(4-(2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-nitrobenzamide (15a)

Compound (15a) was obtained as described in the general procedure starting from 4a and 4-nitrobenzoyl chloride for 2h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: > 300°C (from EtOH). Yield, 15%. TLC (petroleum ether/ethyl acetate 1:1): Rf 0.91. 1H-NMR (DMSO, 400 MHz) δ: 10.90 (1H, s, NHCO), 8.41 (2H, d, J= 8.0 Hz, H-2’, 6’), 8.35 (2H, d, J= 8.4 Hz, H-2”, 6”), 8.24 (2H, d, J= 8.4 Hz, H-3’, 5’), 8.09 (2H, d, J= 8.8 Hz, H-3”, 5”), 8.08-8.00 (2H, m, H-4, 7), 7.58-7.50 (2H, m, H-5, 6). 13C-NMR (DMSO, 100 MHz) δ: 164.2 (C, CO), 149.3 (C, C-4”), 144.4 (C, C-3a, C-7a), 140.3 (C, C-4’), 139.8 (C, C-1”), 135.4 (C, C-1’), 129.3 (CH, C-2”, C-6”), 127.5 (CH, C-5, C-6), 123.6 (CH, C-3”, C-5”), 121.2 (CH, C-2’, C-6’), 120.8 (CH, C-3’, C-5’), 118.1 (CH, C-4, C-7). LC/MS: m/z: 360 (M+H). Anal. Calcd (%) C19H13N5O3: C, 63.51; H, 3.65; N, 19.49. Found: C, 63.40; H, 3.35; N, 19.60.

2.7.4.9. N-(4-(5,6-dimethyl-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-methylbenzamide (8b)

Compound (8b) was obtained as described in the general procedure starting from 4b and 4-methylbenzoyl chloride for 24 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. white solid, m.p.: 295-296°C (from EtOH). Yield, 46%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.53. 1H-NMR (DMSO, 400 MHz) δ: 10.46 (1H, s, NH), 8.25 (2H, d, J= 9.2 Hz, H-2’, 6’), 8.05 (2H, d, J= 9.2 Hz, H-3’, 5’), 7.91 (2H, d, J= 8.4 Hz, H-2”, 6”), 7.76 (2H, s, H-4, 7), 7.37 (2H, d, J= 8.4 Hz, H-3”, 5”), 2.51 (3H, s, CH3), 2.40 (6H, s, 2CH3). 13C-NMR (DMSO, 100 MHz) δ: 165.6 (C, CO), 143.8 (C, C-3a, C-7a), 141.9 (C, C-4”), 139.9 (C, C-4’), 137.9 (C, C-5, C-6), 135.1 (C, C-1’), 131.7 (C, C-1”), 128.9 (CH, C-3”, C-5”), 127.7 (CH, C-2”, C-6”), 121.4 (CH, C-4, C-7), 120.9 (CH, C-2’, C-6’), 116.2 (CH, C-3’, C-5’), 29.9 (CH3, CH3-C4”), 21.0 (CH3, CH3-C5, CH3-C6). LC/MS: m/z: 357 (M+H) Anal. Calcd (%) C22H20N4O: C, 74.14; H, 5.66; N, 15.72. Found: C, 74.24; H, 5.80; N, 16.02.

2.7.4.10. N-(4-(5,6-dimethyl-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)-4-methoxybenzamide (9b)

Compound (9b) was obtained as described in the general procedure starting from 4b and 4-methoxybenzoyl chloride for 24 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Cream solid, m.p.: 285-287°C (from EtOH). Yield, 32%. TLC (petroleum ether/ethyl acetate 6:4): Rf 0.59. 1H-NMR (DMSO, 400 MHz) δ: 10.38 (1H, s, NH), 8.25 (2H, d, J= 8.0 Hz, H-2’, 6’), 8.05 (2H, d, J= 8.4 Hz, H-3’, 5’), 8.01 (2H, d, J= 7.6 Hz, H-2”,6”), 7.76 (2H, s, H-4, 7), 7,09 (2H, d, J= 8.0 Hz, H-3”, 5”), 3.86 (3H, s, OCH3), 2.40 (6H, s, 2CH3). 13C-NMR (DMSO, 100 MHz) δ: 165.1 (C, CO), 162.1 (C, C-4”), 143.8 (C, C-3a, C-7a), 140.0 (C, C-4’), 137.8 (C, C-5, C-6), 134.9 (C, C-1’), 129.7 (CH, C-2”, C-6”), 126.6 (C, C-1”), 120.8 (CH, C-4, C-7), 120.3 (CH, C-2’, C-6’), 116.2 (CH, C-3’, C-5’), 113.6 (CH, C-3”, C-5”), 55.4 (OCH3), 20.4 (CH3, CH3-C5, CH3-C6). LC/MS: m/z: 373 (M+H). Anal. Calcd (%) C22H20N4O2: C, 70.95; H, 5.41; N, 15.04. Found: C, 70.85; H, 5.40; N, 15.44.

2.7.4.11. N-(4-(5,6-dimethyl-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-3,4,5-trimethoxybenzamide (10b)

Compound (10b) was obtained as described in the general procedure starting from 4b and 3,4,5-trimethoxybenzoyl chloride for 24 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. beige solid, m.p.: 272-273°C (from EtOH).Yield, 13%. TLC (petroleum ether/ethyl acetate 6:4): Rf 0.34. 1H-NMR (DMSO, 400 MHz) δ: 10.40 (1H, s, NH), 8.28 (2H, d, J= 8.8 Hz, H-2’,6’), 8.02 (2H, d, J= 9.2 Hz, H-3’, 5’), 7.76 (2H, s, H-2”, 6”), 7.32 (2H, s, H-4, 7), 3.90 (6H, s, 2OCH3), 3.75 (3H, s, OCH3), 2.41 (6H, s, 2CH3). 13C-NMR (DMSO, 100 MHz) δ: 165.1 (C, CO), 152.6 (C, C-3”, C-5”), 143.8 (C, C-3a, C-7a), 140.5 (C, C-4”), 139.7 (C, C-4’), 137.9 (C, C-5, C-6), 135.2 (C, C-1’), 129.7 (C, C-1”), 121.1 (CH, C-4, C-7), 120.3 (CH, C-2’, C-6’), 116.3 (CH, C-3’, C-5’), 105.4 (CH, C-2”, C-6”), 60.1 (OCH3-C4”), 56.1 (OCH3-C3”, OCH3-C5”,), 20.4 (CH3, CH3-C5, CH3-C6). LC/MS: m/z: 433 (M+H). Anal. Calcd (%) C24H24N4O4: C, 66.65; H, 5.59; N, 12.96. Found: C, 66.35; H, 5.42; N, 13.06.

2.7.4.12. 4-chloro-N-(4-(5,6-dimethyl-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)benzamide (11b)

Compound (11b) was obtained as described in the general procedure starting from 4b and 4-chlorobenzoyl chloride for 2 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Whight solid, m.p.: >300°C (from EtOH). Yield, 37%. TLC (petroleum ether/ethyl acetate 6:4): Rf 0.25. 1H-NMR (DMSO, 400 MHz) δ: 10.61 (1H, s, NH), 8.27 (2H, d, J= 8.4 Hz, H-2’, 6’), 8.06-8.02 (4H, m, H-2”, 3”, 5”, 6”), 7.77 (2H, s, H-4, 7), 7.64 (2H, d, J= 8.4 Hz, H-3’, 5’), 2.41 (6H, s, 2CH3). 13C-NMR (DMSO, 100 MHz) δ: 153.6 (C, CO), 143.9 (C, C-3a, C-7a), 143.8 (C, C-4’), 138.8 (C, C-4”), 138.3 (C, C-5, C-6), 138.0 (C, C-1’), 137.9 (C, C-1”), 121.1 (CH, C-2”, C-6”), 120.1 (CH, C-3”, C-5”), 119.2 (CH, C-4, C-7), 116.3 (CH, C-2’, C-3’, C-5’, C-6’), 20.42 (CH3, CH3-C5, CH3-C6). LC/MS: m/z: 377 (M+H). Anal. Calcd (%) C21H17ClN4O: C, 66.93; H, 4.55; N, 14.87. Found: C, 66.83; H, 4.55; N, 15.00.

2.7.4.13. 4-bromo-N-(4-(5,6-dimethyl-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)benzamide (12b)

Compound (12b) was obtained as described in the general procedure starting from 4b and 4-bromobenzoyl chloride for 24 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Whight solid, m.p.: >300°C (from EtOH). Yield, 28%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.58. 1H-NMR (DMSO, 400 MHz) δ: 10.43 (1H, s, NH), 8.36 (2H, s, H-4, 7), 8.23 (2H, d, J= 8.4 Hz, H-2’, 6’), 7.82 (2H, d, J= 8.0 Hz, H-3’, 5’), 7.76 (4H, s, H-2”, 3”, 5”, 6”), 2,40 (6H, s, 2-CH3). 13C-NMR (DMSO, 100 MHz) δ: 164.8 (C, CO), 143.8 (C, C-3a, C-7a), 139.6 (C, C-4’), 137.9 (C, C-5, C-6), 133.7 (C, C-4”), 131.5 (CH, C-3”, C-5”), 129.9 (CH, C-2”, C-6”), 125.6 (C, C-1’, C-1”), 121.0 (CH, C-4, C-7), 120.4 (CH, C-2’, C-6’), 116.3 (CH, C-3’, C-5’), 20.4 (CH3, CH3-C5, CH3-C6). LC/MS: m/z: 422 (M+H). Anal. Calcd (%) C21H17BrN4O: C, 59.87; H, 4.07; N, 13.30. Found: C, 60.87; H, 4.37; N, 13.55.

2.7.4.14. N-(4-(5,6-dimethyl-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-(trifluoromethyl)benzamide (13b)

Compound (13b) was obtained as described in the general procedure starting from 4b and 4-(trifluoromethyl)benzoyl chloride for 24 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. white solid, m.p.: 295-297°C (from EtOH). Yield, 20%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.66. 1H-NMR (DMSO, 400 MHz) δ: 10.76 (1H, s, NH), 8.27 (2H, s, H-4, 7), 8.19 (2H, d, J= 8.0 Hz, H-2’, 6’), 8.06 (2H, t, H-3”, 5”), 7.94 (2H, d, J= 8.0, H-3’, 5’), 7.76 (2H, d, J= 10.0 Hz, H-2”, 6”), 2.40 (6H, s, 2CH3). 13C-NMR (DMSO, 100 MHz) δ: 164.6 (C, CO), 143.8 (C, C-3a, C-7a), 139.9 (C, C-4’), 139.4 (C, C-1”), 138.9 (C, C-1’), 137.9 (C, C-5, C-6), 135.0 (C, C-4”), 131.5 (C, CF3), 128.7 (CH, C-2”, C-6”), 125.4 (CH, C-3”, C-5”), 121.0 (CH, C-4, C-7), 120.4 (CH, C-2’, C-6’), 116.3 (CH, C-3’, C-5’), 20.4 (CH3, CH3-C5, CH3-C6). LC/MS: m/z: 411 (M+H). Anal. Calcd (%) C22H17F3N4O: C, 64.39; H, 4.18; N, 13.65. Found: C, 64.19; H, 4.20; N, 13.84.

2.7.4.15. 4-cyano-N-(4-(5,6-dimethyl-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)benzamide (14b)

Compound (14b) was obtained as described in the general procedure starting from 4b and 4-cyanobenzoyl chloride for 24 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 294-297°C (from EtOH). Yield, 44%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.40. 1H-NMR (DMSO, 400 MHz) δ: 10.76 (1H, s, NH), 8.28 (2H, d, J= 9.2 Hz, H-2’, 6’), 8.14 (2H, d, J= 8.4 Hz, H-2”, 6”), 8.06-8.04 (4H, m, H-3’, 5’, 3”, 5”), 7.76 (2H, s, H-4, 7), 2.40 (6H, s, 2CH3). 13C-NMR (DMSO, 100 MHz) δ: 164.3 (C, CO), 143.8 (C, C-3a, C-7a), 139.3 (C, C-1”), 138.6 (C, C-4’), 137.9 (C, C-5, C-6), 135.5 (C, C-1’), 132.5 (CH, C-3”, C-5”) 128.6 (CH, C-2”, C-6”), 121.1 (CH, C-4, C-7), 120.4 (CH, C-2’, C-6’), 118.2 (C, CN), 116.3 (CH, C-3’, C-5’), 114.0 (C, C-4”), 20.41 (CH3, CH3-C5, CH3-C6). LC/MS: m/z: 368 (M+H). Anal. Calcd (%) C22H17N5O: C, 71.92; H, 4.66; N, 19.06. Found: C, 72.00; H, 4.76; N, 19.36.

2.7.4.16. N-(4-(5,6-dimethyl-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-nitrobenzamide (15b)

Compound (15b) was obtained as described in the general procedure starting from 4b and 4-nitrobenzoyl chloride for 2 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 297-298°C (from EtOH). Yield, 49%. TLC (petroleum ether/ethyl acetate 6:4): Rf 0.75. 1H-NMR (DMSO, 400 MHz) δ: 10.86 (1H, s, NH), 8.40 (2H, d, J= 9.2 Hz, H-3”, 5”), 8.30 (2H, d, J= 7.6 Hz, H-2’, 6’), 8.23 (2H, d, J= 7.6 Hz, H-3’, 5’), 8.06 (2H, d, J= 9.2 Hz, H-2”, 6”), 7.77 (2H, s, H-4, 7), 2.41 (6H, s, 2-CH3). 13C-NMR (DMSO, 100 MHz) δ: 165.8 (C, CO), 150.0 (C, C4”), 143.9 (C, C-3a, C-7a), 143.8 (C, C-4’), 138.2 (C, C-5, C-6), 138.0 (C, C-1”), 136.4 (C, C-1’), 130.7 (CH, C-2”, C-6”), 129.4 (CH, C-4, C-7), 123.7 (CH, C-3”, C-5”), 121.0 (CH, C-2’, C-6’), 116.3 (CH, C-3’, C-5’), 20.4 (CH3, CH3-C5, CH3-C6). LC/MS: m/z: 388 (M+H). Anal. Calcd (%) C21H17N5O3: C, 65.11; H, 4.42; N, 18.08. Found: C, 65.00; H, 4.12; N, 18.28.

2.7.4.17. N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-methylbenzamide (8c)

Compound (8c) was obtained as described in the general procedure starting from 4c and 4-methylbenzoyl chloride for 72 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 249-250°C (from EtOH). Yield, 17%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.59. 1H-NMR (DMSO, 400 MHz) δ: 10.50 (1H, br s, NH), 8.32 (2H, d, J = 8 Hz, H-2”,6”), 8.10 (2H, d, J = 8.8 Hz, H-2'-6'), 7.93-7.83 (3H, m, H-3'-5' e H-7), 7.53-7.48 (1H, m, H-6), 7.48-.7.29 (3H, m, H-3”,5” and H-5), 2.40 (3H, s, CH3). 13C-NMR (DMSO, 100 MHz) δ: 165.8 (C, CO), 151.3 (C, C-4), 146.9 (C, C-7a), 146.3 (C, C-4”), 142.1 (C, C-4’), 140.5 (C, C-1’), 134.6 (C, C-3a), 131.4 (C, C-1”), 129.0 (CH, C-3”, C-5”), 127.7 (CH, C-2”, C-6”), 121.3 (CH, C-6), 121.0 (CH, C-2’, C-3’, C-5’, C-6’), 120.7 (CH, C-7), 115.2 (CH, C-5), 21.0 (CH3). LC/MS: m/z 347 (M+H). Anal. Calcd. (%) C20H15FN4O: C, 69.35; H, 4.37; N, 16.18. Found: C, 69.41; H, 4.43; N, 16.21.

2.7.4.18. N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-methoxybenzamide (9c)

Compound (9c) was obtained as described in the general procedure starting from 4c and 4-methoxybenzoyl chloride for 168 h. The crude product was purified by silica gel column chromatography eluting with a 8:2 mixture of petroleum ether/ethyl acetate. Cream solid, m.p.: 223-225°C (from EtOH). Yield, 15%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.42. 1H-NMR (DMSO, 400 MHz): 10.42 (1H, br s, NH), 8.32 (2H, d, J = 8.4 Hz, H-2”, 6”), 8.06 (2H, d, J = 8.4 Hz, H-2', 6'), 8.01 (2H, d, J = 8 Hz, H-3'-5'), 7.88 (1H, d, J = 8.4 Hz, H-7), 7.53-7.48 (1H, m, H-6), 7.34 (1H, t, H-5), 7.10 (2H, d, J = 8 Hz, H-3”,5”), 2.56 (3H, s, OCH3). 13C-NMR (DMSO, 100 MHz) δ: 165.1 (C, CO). 162.1 (C, C-4), 151.5 (C, C-4“), 146.9 (C, C-7a), 144.3 (C, C-1‘), 140.9 (C, C-1“), 134.4 (C, C-3a), 129.7 (CH, C-2“, C-6“), 127.7 (CH, C-6), 126.5 (C, C-4‘), 121.0 (CH, C-2‘, C-6‘), 120.8 (CH, C-3‘, C-5‘), 118.0 (CH, C-7), 114.6 (CH, C-3“, C-5“), 112.6 (CH, C-5), 55.4 (OCH3). LC/MS: m/z 363 (M+H). Anal. Calcd. (%) C20H15FN4O2: C, 66.29; H, 4.17; N, 15.46. Found: C, 66.38; H, 4.25; N, 15.54.

2.7.4.19. N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-3,4,5-trimethoxybenzamide (10c)

Compound (10c) was obtained as described in the general procedure starting from 4c and 3,4,5-trimethoxybenzoyl chloride for 72 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Orange solid, m.p.: 216-219°C (from EtOH). Yield, 26%. TLC (petroleum ether/ethyl acetate 6:4): Rf 0.46. 1H-NMR (DMSO, 400 MHz) δ: 10.45 (1H, br s, NH), 8.35 (2H, d, J = 8.4 Hz, H-3',5'), 8.07 (2H, d, J = 8.4 Hz, H-2', 6'), 7.89 (1H, d, J = 8.8 Hz, H-7), 7.54-7.48 (1H, m, H-6), 7.37-7.34 (1H, m, H-5), 7.32 (2H, s, H-2”, 6”), 3.92 (6H, s, CH3), 3.755 (3H, s, CH3).13C-NMR (DMSO, 100 MHz) δ: 165.2 (C, CO), 152.6 (C, C-4), 151.5 (C, C-3”, C-5”), 146.9 (C, C-7a), 140.5 (C, C-4”), 135.0 (C, C-3a), 134.7 (C, C-1’), 129.6 (C, C-4’), 127.7 (CH, C-6), 121.1 (CH, C-2’, C-3’, C-5’, C-6’), 114.6 (CH, C-7), 110.8 (CH, C-5), 105.4 (CH, C-2”, C-6”), 60.1 (CH3, OCH3-C4”), 56.1 (CH3, OCH3-C3”, OCH3-C5”). LC/MS: m/z 423 (M+H). Anal. Calcd. (%) C22H19FN4O4: C, 62.55; H, 4.53; N, 13.26. Found: C, 62.61; H, 4.60; N, 13.30.

2.7.4.20. 4-chloro-N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)benzamide (11c)

Compound (11c) was obtained as described in the general procedure starting from 4c and 4-chlorobenzoyl chloride for 192 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Wight solid, m.p.: 281-283°C (from EtOH). Yield, 69%. TLC (petroleum ether/ethyl acetate 8:2): Rf 0.43. 1H-NMR (DMSO, 400 MHz) δ: 10.63 (1H, br s, NH), 8.33 (2H, d, J = 8.8 Hz, H-2”,6”), 8.08(2H, d, J = 8.8 Hz, H-3”, 5”), 8.03 (2H, d, J = 8 Hz, H-3', 5'), 7.92 (1H, s, H-7), 7.63 (2H, d, J = 8 Hz, H-2', 6'), 7.54-7.51 (2H, m, H-5,6).13C-NMR (DMSO, 100 MHz) δ: 164.7 (C,CO), 145.2 (C, C-4), 144.4 (C, C-7a), 140.0 (C, C-1’), 137.6 (C, C-4”), 136.6 (C, C-1”), 135.1 (C, C-3a), 133.3 (C, C-4’), 129.7 (CH, C-3”, C-5”), 128.5 (CH, C-2”, C-6”), 127.5 (CH, C-6), 121.1 (CH, C-7), 121.0 (CH, C-2’, C-6’), 120.7 (CH, C-3’, C-5’), 118.1 (CH, C-5). LC/MS: m/z 369 (M+H). Anal. Calcd. (%) C19H12ClFN4O: C, 62.22; H, 3.30; N, 15.28. Found: C, 62.30; H, 3.38; N, 15.34.

2.7.4.21. 4-bromo-N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)benzamide (12c)

Compound (12c) was obtained as described in the general procedure starting from 4c and 4-bromobenzoyl chloride for 168 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Wight solid, m.p.: 285-286°C (from EtOH). Yield, 9%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.60. 1H-NMR (DMSO, 400 MHz) δ: 10.64 (1H, br s, NH), 8.32 (2H, d, J = 7.6 Hz, H-2”,6”), 8.07 (2H, d, J = 7.6 Hz, H-3”,5”), 8.03 (1H, d, J = 7.4 Hz, H-7), 7.96 (2H, d, J = 7.6 Hz, H-3',5'), 7.78 (2H, d, J = 7.6 Hz, H-2'-6'), 7.53-7.51 (1H, m, H-6), 7.34 (1H, t, H-5). 13C-NMR (DMSO, 100 MHz) δ: 164.9 (C, CO). 151.5 (C, C-4), 144.3 (C, C-7a), 140.0 (C, C-1’), 139.8 (C, C-1”), 135.2 (C, C-3a), 133.5 (C, C-4’), 131.5 (CH, C-3”, C-5”), 129.8 (CH, C-2”. C-6”), 127.6 (CH, C-6), 125.6 (C, C-4”), 121.1 (CH, C-7), 121.0 (CH, C-2’, C-6’), 120.8 (CH, C-3’, 5’), 118.0 (CH, C-5). LC/MS: m/z 412 (M+H). Anal. Calcd. (%) C19H12BrFN4O: C, 55.49; H, 2.94; N, 13.62. Found: C, 55.53; H, 2.98; N, 13.68.

2.7.4.22. N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-(trifluoromethyl)benzamide (13c)

Compound (13c) was obtained as described in the general procedure starting from 4c and 4-(trifluoromethyl)benzoyl chloride for 72 h. The crude product was purified by silica gel column chromatography eluting with a 8:2 mixture of petroleum ether/ethyl acetate. Beige solid, m.p.: 218-220°C (from EtOH). Yield, 22%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.15. 1H-NMR (DMSO, 400 MHz) δ: 10.79 (1H, 1, br s, NH), 8.32 (2H, d, J = 8.8 Hz, H- 2”, 6”), 8.15 (2H, d, J = 7.6 Hz, H-3'-5'), 8.07-7.10 (3H, m, H-3”,5”, H-7), 7.92 (2H, d, J = 7.6 Hz, H-2',6'), 7.52-7.47 (1H, m, H-6), 7.32 (1H, t, H-5). 13C-NMR (DMSO, 100 MHz) δ: 164.8 (C, CO). 151.4 (C, C-4), 144.3 (C, C-7a), 139.8 (C, C-1‘), 138.3 (C, C-1“), 135.1 (C, C-3a), 131.6 (C, C-4“), 128.6 (CH, C-2“, C-6“), 127.6 (CH, C-6), 125.4 (CH, C-7), 125.2 (C, C-1“), 122.5 (C, CF3), 121.1 (CH, C-3“, C-5“), 120.8 (CH, C-2‘, C-6‘), 118.0 (CH, C-3‘, C-5‘), 112.6 (CH, C-5). LC/MS: m/z 401 (M+H). Anal. Calcd. (%) C20H12F4N4O: C, 60.00; H, 3.02; N, 14.00. Found: C, 60.09; H, 3.08; N, 14.10.


2.7.4.23. 4-cyano-N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)benzamide (14c)

Compound (14c) was obtained as described in the general procedure starting from 4c and 4-cyanobenzoyl chloride for 144 h. The crude product was purified by silica gel column chromatography eluting with a 6:4 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 234-235°C (from EtOH). Yield, 21%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.20. 1H-NMR (DMSO, 400 MHz) δ: 10.57 (1H, br s, NH), 8.34 (1H, s, H-7), 8.26 (2H, d, J= 8.8 Hz, H-3”,5”), 7.98 (2H, d, J = 6.8 Hz, H-2', 6'),7.84 (2H, d, J = 8.8 Hz, H-2”-6”), 7.50 (2H, d, J = 6.8 Hz, H-3'-5'), 7.32-7.28 (1H, m, H-6), 7.30 (1H, t, H-5). 13C-NMR (DMSO, 100 MHz) δ: 151.5 (C, CO), 146.9 (C, C-4), 144.3 (C, C-7a), 139.6 (C, C-1’), 139.5 (C, C-1”), 139.2 (C, C-4’), 135.2 (C, C-3a), 135.0 (C, CN), 134.6 (C, C-4”), 127.5 (CH, C-3”, C-5”), 121.5 (CH, C-6), 121.3 (CH, C-7), 121.0 (CH, C-2”, C-6”), 119.9 (CH, C-2’, C-6’), 118.0 (CH, C-3’, C-5’), 118.0 (CH, C-5). LC/MS: m/z 358 (M+H). Anal. Calcd. (%) C20H12FN5O: C, 67.22; H, 3.38; N, 19.60. Found: C, 67.31; H, 3.43; N, 19.70.

2.7.4.24. N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-4-nitrobenzamide (15c)

Compound (15c) was obtained as described in the general procedure starting from 4c and 4-nitrobenzoyl chloride for 144 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Light yellow solid, m.p.: 315-317°C (from EtOH). Yield, 79%. TLC (petroleum ether/ethyl acetate 6:4): Rf 0.63. 1H-NMR (DMSO, 400 MHz) δ: 10.88 (1H, br s, NH), 8.39 (2H, d, J = 8.4 Hz, H-2”,6”), 8.36-8.33 (2H, m, H-2',6'), 8.22 (2H, d, J = 8.4 Hz, H-3”, 5”),8.11-8.01 (2H, m, H-3',5'), 7.88 (1H, d, J = 8.4 Hz, H-7), 7.53-7.48 (1H, m, H-6),7.34 (1H, t, H-5). 13C-NMR (DMSO, 100 MHz) δ: 164.2 (C, CO), 151.5 (C, C-4), 146.9 (C, C-7a), 144.4 (C, C-NO2), 140.2 (C, C-4’), 139.8 (C, C-1”), 135.3 (C, C-3a), 135.0 (C, C-1’), 129.0 (CH, C-2”, C-6”), 127.7 (CH, C-6), 123.6 (CH, C-3”, C-5”), 121.1 (CH, C-2’, C-6’), 121.1 (CH, C-7), 120.8 (CH, C-3’, C-5’), 110.8 (CH, C-5). LC/MS: m/z 378 (M+H). Anal. Calcd. (%) C19H12FN5O3: C, 60.48; H, 3.21; N, 18.56. Found: C, 60.52; H, 3.28; N, 18.62.

2.7.5. General procedure for the preparation of 3-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)ureaderivatives (16c-26c).

To a solution of 4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)aniline (4c) (200 mg, 0.87 mmol) in N,N-dimethylacetamide (DMA, 7 ml) or toluene (7 ml) an excess (2.61 mmol) of the required isocyanate derivatives was added. The resulting solution was stirred at 110°C for different times as reported below, then it was cooled to room temperature and crushed ice was added. The solid obtained in each reaction was filtered under vacuum. Purification by flash chromatography using as eluting system, a mixture of petroleum ether/ethyl acetate or dichloromethane/ethyl acetate in different ratios as reported below, furnished the urea derivatives 16c-26c.

2.7.5.1. 1-ethyl-3-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)urea (16c)

Compound (16c) was obtained as described in the general procedure starting from 4c and ethyl isocyanate in DMA for 120 h. The crude product was purified by silica gel column chromatography eluting with a 1:1 mixture of petroleum ether/ethyl acetate. White solid, m.p.: 345-348°C (from EtOH). Yield, 38%. TLC (petroleum ether/ethyl acetate 1:1): Rf 0.38. 1H-NMR (DMSO, 400 MHz) δ: 8.86 (1H, br s, NH), 8.19 (2H, d, J = 7.6 Hz, H-2',6'), 7.86 (1H, d, J = 7.4 Hz, H-7), 7.68 (2H, d, J = 8.8 Hz, H-3',5'), 7.47-7.51 (1H, m, H-6), 7.32 (1H, t, H-5), 6.27 (1H, br t, NH), 3.15 (2H, m, CH2), 1.08 (3H, t, CH3). 13C-NMR (DMSO, 100 MHz) δ: 154.8 (C, CO), 151.4 (C, C-4), 146.8 (C, C-7a), 142.1 (C, C-1‘), 135.2 (C, C-3a), 132.6 (C, C-4‘), 127.4 (CH, C-6), 121.0 (CH, C-3‘, C-5‘), 118.4 (CH, C-2‘, C-6‘), 114.4 (CH, C-7), 110.5 (CH, C-5), 34.0 (CH2, CH2CH3), 15.3 (CH3, CH2CH3). LC/MS: m/z 300 (M+H). Anal. Calcd. (%) C15H14FN5O: C, 60.19; H, 4.71; N, 23.40. Found: C, 60.32; H, 4.81; N, 23.51.

2.7.5.2. 1-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-3-propylurea (17c)

Compound (17c) was obtained as described in the general procedure starting from 4c and 1-propyl isocyanate in DMA for 72 h. The crude product was purified by silica gel column chromatography eluting with a 6:4 mixture of petroleum ether/ethyl acetate. Cream solid, m.p.: 321-324°C (from EtOH). Yield, 46%. TLC (petroleum ether/ethyl acetate 6:4): Rf 0.32. 1H-NMR (DMSO, 400 MHz) δ: 8.84 (1H, br s, NH), 8.19 (2H, d, J = 7.6 Hz, H-2',6'), 7.86 (1H, d, J = 7.4 Hz, H-7), 7.68 (2H, d, J = 8.8 Hz, H-3',5'), 7.50-7.45 (1H, m, H-6), 7.31 (1H, t, H-5),6.30 (1H, br t, NH), 3.08 (2H, q, CH2), 1.47 (2H, sext, CH2), 0.89 (3H, t, CH3). 13C-NMR (DMSO, 100 MHz) δ: 155.0 (C, CO), 151.4 (C, C-4), 146.8 (C, C-7a), 142.2 (C, C-1‘), 135.1 (C, C-3a), 133.5 (C, C-4‘), 127.5 (CH, C-6), 121.2 (CH, C-3‘, C-5‘), 118.2 (CH, C-2‘, C-6‘), 114.4 (CH, C-7), 110.5 (CH, C-5), 40.9 (CH2, COCH2), 22.8 (CH2, CH2CH3), 11.2 (CH3, CH2CH3). LC/MS: m/z 314 (M+H). Anal. Calcd. (%) C16H16FN5O: C, 61.33; H, 5.15; N, 22.35. Found: C, 61.42; H, 5.20; N, 22.42.

2.7.5.3. 1-butyl-3-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)urea (18c)

Compound (18c) was obtained as described in the general procedure starting from 4c and 1-butyl isocyanate in DMA for 96 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Brown solid, m.p.: 243-245°C (from EtOH). Yield, 51%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.42. 1H-NMR (DMSO, 400 MHz) δ: 8.84 (1H, br s, NH), 8.18 (2H, d, J = 8.8 Hz, H-3̍, 5̍), 7.85 (1H, d, J= 8.4 Hz, H-7), 7.67 (2H, d, J = 8.8 Hz, H-2̍, 6̍), 7.50-7.45 (1H, m, H-6), 7.31 (1H, t, H-5), 6.28 (1H, br t, NH), 3.12 (2H, d, CH2), 1.44 (2H, q, CH2), 1.33 (2H, sex, CH2), 0.90 (3H, t, CH3).13C-NMR (DMSO, 100 MHz) δ: 154.9 (C, CO), 151.3 (C, C-4), 146.7 (C, C-7a), 142.0 (C, C-1‘), 135.1 (C, C-3a), 132.6 (C, C-4‘), 127.5 (CH, C-6), 121.1 (CH, C-3‘, 5‘), 118.0 (CH, C-2‘, C-6‘), 116.3 (CH, C-7), 112.4 (CH, C-5), 39.2 (CH2, COCH2), 31.6 (CH2, CH2CH2CH2), 19.4 (CH2, CH2CH3), 13.6 (CH3, CH2CH3). LC/MS: m/z 328 (M+H). Anal. Calcd. (%) C17H18FN5O: C, 62.37; H, 5.54; N, 21.39. Found: C, 62.41; H, 5.67; N, 21.43.

2.7.5.4. 1-(sec-butyl)-3-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)urea (19c)

Compound (19c) was obtained as described in the general procedure starting from 4c and sec-butyl isocyanate in DMA for 144 h. The crude product was purified by silica gel column chromatography eluting with a 75:25 mixture of petroleum ether/ethyl acetate. White solid, m.p.: 252-255°C (from EtOH). Yield, 42%. TLC (petroleum ether/ethyl acetate 75:25): Rf 0.32. 1H-NMR (DMSO, 400 MHz) δ: 8.71 (1H, br s, NH), 8.17 (2H, d, J = 8.8 Hz, H-3̍, 5̍), 7.86 (1H, d, J= 8.4 Hz, H-7), 7.42 (2H, d, J = 8.8 Hz, H-2̍, 6̍), 7.34-7.30 (1H, m, H-6), 7.31 (1H, t, H-5), 6.128 (1H, br t, NH), 3.63 (1H, sept, CH), 1.45 (2H, quin, CH2), 1.10 (3H, d, CH3), 0.89(3H, t, CH3). 13C-NMR (DMSO, 100 MHz) δ: 152.7 (C, CO), 148.5 (C, C-4), 146.8 (C, C-7a), 144.2 (C, C-1‘), 142.0 (C, C-3a), 132.7 (C, C-4‘), 127.3 (CH, C-6), 121.2 (CH, C-3‘, 5‘), 120.9 (CH, C-7), 117.9 (CH, C-2‘, C-6‘), 114.4 (CH, C-5), 46.2 (CH, CH-CH3), 29.2 (CH2, CH2-CH3), 20.6 (CH3, CH-CH3), 10.3 (CH3, CH2-CH3). LC/MS: m/z 328 (M+H). Anal. Calcd. (%) C17H18FN5O: C, 62.37; H, 5.54; N, 21.39. Found: C, 62.42; H, 5.60; N, 21.44.

2.7.5.5. 1-cyclopentyl-3-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)urea (20c)

Compound (20c) was obtained as described in the general procedure starting from 4c and cyclopentyl isocyanate in DMA for 168 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Cream solid, m.p.: 339-341°C (from EtOH). Yield, 23%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.27. 1H-NMR (DMSO, 400 MHz) δ: 8.71 (1H, br s, NH), 8.17 (2H, d, J = 8.8 Hz, H-3̍, 5̍), 8.01 (1H, s, H-7), 7.65 (2H, d, J = 8.8 Hz, 2̍, 6̍), 7.50-7.49 (2H, m, H-5), 6.32 (1H, br d, NH), 3.00-3.97 (1H, m, CH cyclopentyl), 1.87-1.82 (2H, m, CH2 cyclopentyl), 1.65-1.55 (4H, m, CH2, cyclopentyl), 1.40-1.39 (2H, m, CH2 cyclopentyl). 13C-NMR (DMSO, 100 MHz) δ: 154.6 (C, CO). 144.7 (C, C-4), 144.2 (C, C-7a), 142.0 (C, C-1‘), 139.4 (C, C-4‘), 133.0 (C, C-3a), 127.2 (CH, C-6), 121.0 (CH, C-3‘, C-5‘), 117.9 (CH, C-2‘, C-6‘), 114.4 (CH, C-7), 110.6 (CH, C-5), 50.9 (CH, CH-NH), 32.7 (CH2,CH2-CH), 23.1 (CH2, CH2-CH), 22.5 (CH2, CH2-CH2), 21.2 (CH2, CH2-CH2). LC/MS: m/z 340 (M+H). Anal. Calcd. (%) C18H18FN5O: C, 63.70; H, 5.35; N, 20.64. Found: C, 63.81; H, 5.43; N, 20.70.

2.7.5.6. 1-cyclohexyl-3-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)urea (21c)

Compound (21c) was obtained as described in the general procedure starting from 4c and cyclohexyl isocyanate in DMA for 72 h. The crude product was purified by silica gel column chromatography eluting with a 7:3 mixture of petroleum ether/ethyl acetate. Cream solid, m.p.: 212-214°C (from EtOH). Yield, 86%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.46. 1H-NMR (DMSO, 400 MHz) δ: 8.73 (1H, br s, NH), 8.28 (2H, d, J = 8.4 Hz, H-3̍, 5̍), 7.86 (1H, d, J= 8.8 H-7), 7.66 (2H, d, J = 8.4, H-2̍, 6̍), 7.51-7.46 (1H, m, H-6), 7.36- 7.29 (1H, m, H-5), 6.23 (1H, br d, NH), 1.84-1.49 (6H, m, H-cyclohexyl), 1.37-1.11 (5H, m, H- cyclohexyl). 13C-NMR (DMSO, 100 MHz) δ: 156.6 (C, CO). 154.1 (C, C-4), 151.4 (C, C-1‘), 146.8 (C, C-7a), 142.2 (C, C-4‘), 135.2 (C, C-3a), 127.4 (CH, C-6), 121.2 (CH, C-3‘, C-5‘), 117.8 (CH, C-2‘, C-6‘), 114.4 (CH, C-7), 110.5 (CH, C-5), 47.6 (CH, CH-NH), 33.3 (CH2, CH2-CH), 32.8 (CH2, CH2-CH), 25.2 (CH2), 24.3 (CH2), 22.4 (CH2). LC/MS: m/z 354 (M+H). Anal. Calcd. (%) C19H20FN5O: C, 64.57; H, 5.70; N, 19.82. Found: C, 64.61; H, 5.79; N, 19.88.

2.7.5.7. 1-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-3-(naphthalen-1-yl)urea (22c)

Compound (22c) was obtained, pure, as described in the general procedure starting from 4c and 1-naphthylisocyanate in DMA for 24 h. White solid, m.p.: >350°C (from EtOH). Yield, 40%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.36. 1H-NMR (DMSO, 400 MHz) δ: 9.47 (1H, br s, NH), 8.90 (1H, br s, NH), 8.28 (2H, d, J = 8.8 Hz, H-2', 6'), 8.14 (1H, d, J = 8.4 Hz, H-naphthalene), 8.02-7.95 (3H, m, H-6, 2H-naphthalene), 7.88 (1H, d, J= 8.4 Hz, H-7), 7.80 (2H, d, J = 8.8 Hz, H-3', 5'), 7.70-7.48 (4H, m, H-naphthalene), 7.33 (1H, t, H-5). 13C-NMR (DMSO, 100 MHz) δ: 152.9 (C, CO). 152.7 (C, C-4), 150.1 (C, C-7a), 144.2 (C, C-1“), 141.2 (C, C-4‘), 135.2 (C, C-3a), 133.7 (C, C-4a“), 133.3 (C, C-1‘), 128.4 (CH, C-5“, 7“), 127.6 (CH, C-6), 126.3 (C, C-8a“), 126.0 (CH, C-3“, C-6“), 123.6 (CH, C-2‘, C-6‘), 123.6 (CH, C-4“), 118.7 (CH, C-3‘, C-5‘), 117.9 (CH, C-8“), 118.4 (CH, C-7), 114.4 (CH, C-5), 110.6 (CH, C-2“). LC/MS: m/z 398 (M+H). Anal. Calcd. (%) C23H16FN5O: C, 69.51; H, 4.06; N, 17.62. Found: C, 69.82; H, 4.25; N, 17.71.

2.7.5.8. 1-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-3-(4-methoxyphenyl)urea (23c)

Compound (23c) was obtained as described in the general procedure starting from 4c and 4-methoxyphenyl isocyanate in toluene for 96 h. The crude product was purified by silica gel column chromatography eluting with a 9.5:0.5 mixture of dichloromethane/ethyl acetate. Light pink solid, m.p.: 274-276°C (from EtOH). Yield, 33%. TLC (dichloromethane/ethyl acetate 9.5:0.5): Rf 0.36. 1H-NMR (DMSO, 400 MHz) δ: 9.08 (1H, br s, NH), 8.67 (1H, br s, NH),8.25 (2H, d, J = 8.8 Hz, H-2', 6'), 7.88 (1H, d, J= 8.8 Hz H-7), 7.74 (2H, d, J = 9.2 Hz, H-2”, 6”),7.53-7.47 (1H, m, H-6), 7.40 (2H, d, J = 8.8 Hz, H-3', 5'), 7.36- 7.31 (1H, m, H-5), 6.90 (2H, d, J = 9.2 Hz, H-3”, 5”),3.73 (3H, s, OCH3). 13C-NMR (DMSO, 100 MHz) δ: 156.0 (C, CO), 154.8 (C, C-4), 152.6 (C, C-4“), 152.4 (C, C-7a), 141.3 (C, C-1‘), 136.0 (C, C-3a), 132.2 (C, C-1“), 132.0 (C, C-4‘), 127.7 (CH, C-6), 121.3 (CH, C-2“, C-6“), 120.4 (CH, C-3‘, C-5‘), 118.6 (CH, C-2‘, C-6‘), 114.5 (CH, C-3“, C-5“), 114.0 (CH, C-7), 110.6 (CH, C-5), 55.2 (CH3, OCH3). LC/MS: m/z 378 (M+H). Anal. Calcd. (%) C20H16FN5O2: C, 63.65; H, 4.27; N, 18.56. Found: C, 63.71; H, 4.34; N, 18.65.

2.7.5.9. 1-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-3-(3,4,5-trimethoxyphenyl)urea (24c)

Compound (24c) was obtained, pure, as described in the general procedure starting from 4c and 3, 4, 5-trimethoxyphenyl isocyanate in toluene for 20 h. White solid, m.p.: 272-274°C (from EtOH). Yield, 73%. TLC (petroleum ether/ethyl acetate 1:1): Rf 0.32. 1H-NMR (DMSO, 400 MHz) δ: 9.06 (1H, br s, NH), 8.77 (1H, br s, NH), 8.20 (2H, d, J = 8.8 Hz, H-2', 6'),7.83 (1H, d, J= 8.4 Hz H-7), 7.70 (2H, d, J = 8.8 Hz, H-3', 5'), 7.51- 7.46 (1H, m, H-6), 7.29 (1H, m, H-5), 6.80 (2H, s, H-2”,6”), 3.77 (6H, s, OCH3), 3.60 (3H, s, OCH3). 13C-NMR (DMSO, 100 MHz) δ: 152.8 (C, CO), 152.6 (C, C-4), 150.1 (C, C-3“, C-5“), 146.8 (C, C-7a), 140.9 (C, C-1“), 140.5 (C, C-1‘), 140.2 (C, C-4“), 135.1 (C, C-3a), 133.4 (C, C-4‘), 121.3 (CH, C-6), 119.0 (CH, C-3‘, C-5‘), 117.8 (CH, C-7), 114.4 (CH, C-2‘, C-6‘), 110.7 (CH, C-2“, C-6“), 96.3 (CH, C-5), 60.2 (CH3, OCH3-C4”), 55.7 (CH3, OCH3-C3”, OCH3-C5”). LC/MS: m/z 438 (M+H). Anal. Calcd. (%) C22H20FN5O4: C, 60.41; H, 4.61; N, 16.01. Found: C, 60.51; H, 4.67; N, 16.10.

2.7.5.10. 1-(4-chlorophenyl)-3-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)urea (25c)

Compound (25c) was obtained, pure, as described in the general procedure starting from 4c and 4-chlorophenyl isocyanate in toluene for 3.5 h. White solid, m.p.: 241-244°C (from EtOH). Yield, 63%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.20. 1HNMR (DMSO, 400 MHz) δ: 9.06 (1H, br s, NH), 8.91 (1H, br s, NH), 8.23 (2H, d, J = 8.8 Hz, H-6”,5”), 8.09-8.06 (1H, m, H-6), 7.94 (1H, d, J= 8.4 Hz, H-7), 7.81 (2H, d, J = 8.8 Hz, H-2”, 6”), 7.58 (2H, d, J = 8.8 Hz, H-2', 6'), 7.41 (2H, d, J = 8.8 Hz, H-3', 5'), 7.29 (1H, t, H-5). 13C-NMR (DMSO, 100 MHz) δ: 153.1 (C, CO), 151.6 (C, C-4), 147.3 (C, C-7a), 144.7 (C, C-1‘), 141.4 (C, C-1“), 138.5 (C, C-3a), 133.9 (C, C-4“), 129.1 (CH, C-3“, C-5“), 126.31 (C, C-4‘), 121.8 (CH, C-6), 120.5 (CH, C-2“, C-6“), 119.3 (CH, C-3‘, C-5‘), 118.4 (CH, C-2‘, C-6‘), 114.9 (CH C-7), 111.2 (CH, C-5). LC/MS: m/z 384 (M+H). Anal. Calcd. (%) C19H13ClFN5O: C, 59.77; H, 3.43; N, 18.34. Found: C, 59.86; H, 3.62; N, 18.42.

2.7.5.11. 1-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl)-3-(4-fluorophenyl)urea (26c)

Compound (26c) was obtained, pure, as described in the general procedure starting from 4c and 4-fluorophenyl isocyanate in toluene for 48 h. White solid, m.p.: 346-347°C (from EtOH). Yield, 38%. TLC (petroleum ether/ethyl acetate 7:3): Rf 0.47. 1H-NMR (DMSO, 400 MHz) δ: 9.05 (1H, br s, NH), 8.80 (1H, br s, NH), 8.22 (2H, d, J = 8.0 Hz, H-2', 6'), 7.84 (1H, d, J= 8.8 Hz, H-7), 7.72 (2H, d, J = 8.0 Hz, H-3', 5'),7.49- 7.46 (3H, m, H-6, 2”, 6”), 7.29 (1H, t, H-5), 7.13 (2H, t, H-3”,5”). 13C-NMR (DMSO, 100 MHz) δ: 158.0 (C, CO), 152.9 (C, C-4), 151.9 (C, C-4“), 147.3 (C, C-7a), 144.7 (C, C-1‘), 144.8 (C, C-1“), 136.2 (C, C-3a), 133.8 (C, C-4‘), 121.7 (CH, C-2“, C-6“), 120.7 (CH, C-6), 119.2 (CH, C-3‘, C-5‘), 115.9 (CH, C-2‘, 6‘), 115.6 (CH, C-3“, C-5“), 115.0 (CH, C-7), 111.1 (CH, C-5). LC/MS: m/z 366 (M+H). Anal. Calcd. (%) C19H13F2N5O: C, 62.46; H, 3.59; N, 19.17. Found: C, 62.53; H, 3.65; N, 19.26.

3. RESULTS AND DISCUSSION

3.1. Chemistry

Amines 4a,b were prepared according to the procedures we have already reported [23Carta, A.; Bua, A.; Corona, P.; Piras, S.; Briguglio, I.; Molicotti, P.; Zanetti, S.; Laurini, E.; Aulic, S.; Fermeglia, M.; Pricl, S. Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase. Eur. J. Med. Chem., 2019, 161, 399-415.
[http://dx.doi.org/10.1016/j.ejmech.2018.10.031] [PMID: 30384044]
] while N-(4-nitrophenyl) derivatives (1-3) and N-(4-aminophenyl) derivative (4c) were synthesized starting from 4-fluorobenzotriazole as previously described [46] and 1-chloro-4-nitrobenzene in dimethylacetamide (DMA) and Cs2CO3, to afford the desired 4-fluoro-2-(4-nitrophenyl)-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazole (2) in 37% yield and traces of 7-fluoro-1-(4-nitrophenyl)-1H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazole (1) and 4-fluoro-1-(4-nitrophenyl)-1H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazole (3) in 1-2% of yield. The reduction of derivative 2, dissolved in ethanol, with hydrazine hydrate in the presence of 10% Palladium on activated charcoal gave the desired 4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)aniline (4c) in over 50% of yield Scheme. (1).

As shown in Supplementary Material, the correct position of the side chain on the triazole moiety of intermediates 1-3, has been determined by analysis of the chemical shifts of C-3a, C-7a and C-1’, as previously reported [24Carta, A.; Sanna, P.; Paglietti, G.; Sparatore, F. 13C-NMR as useful tool for unambiguous identification of ring substituted n1(2)(3)-alkylbenzotriazole isomers. Heterocycles, 2001, 55(6), 1133.
[http://dx.doi.org/10.3987/COM-01-9189]
], and verified with bidimensional techniques (NOESY and HMBC), see Figure SM3-SM11.

As reported in Scheme. (2), condensation of 4c with the appropriate anhydride (acetic, propionic or butyric anhydride), afforded the corresponding amides (5-7) in 26-31% of yield. While the condensation of 4c, in N,N-dimethylacetamide or toluene, with either required benzoyl chloride or isocyanate derivatives, afforded the N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)benzamide derivatives (8c-15c) in 9-79% of yield and 3-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)urea derivatives (16c-26c) in 23-86% of yield, respectively. Condensation of compounds 4a,b with benzoyl chloride leads to the formation of derivatives 8a,b-15a,b.

3.2. Biology

Derivatives (5c-7c), (8a,b,c-15a,b,c) and (16c-26c), depicted in Scheme. (II), were tested against representative members of several RNA and DNA viruses families in cell-based assays (results reported in Supplementary Material, Table SM1). In detail, ssRNA- viruses: Vesicular Stomatitis Virus (VSV) (Rhabdoviridae) and human respiratory syncytial virus (hRSV) (Pneumoviridae); ssRNA+ viruses: BVDV and YFV (Flaviviridae) and two Picornaviridae: human enterovirus B (Coxsackievirus B5, CV-B5) human enterovirus C (poliovirus type-1, Sb-1); dsRNA viruses: reovirus type-1 (Reo-1) (Reoviridae); DNA virus: human herpesvirus 1 (herpes simplex type-1, HSV-1) (Herpesviridae) and vaccinia virus (VV) (Poxviridae). As reference drugs were used 2'-C-methylcytidine (NM 107), ribavirin, 6-azauridine, acycloguanosine (ACG), pleconaril and mycophenolic acid (MPA). Furthermore, the cytotoxicity of all compounds was also evaluated in parallel with the antiviral activity.

Scheme 1
Synthetic routes for synthesis of derivatives 1-3,4c. i: NaNO2, HCl, 0°C, then r.t. 24h; ii: DMA, Cs2CO3, 75°C, 36h; iii: NH2-NH2, C/Pd, EtOH 110°C, 20h.


Scheme 2
Synthetic routes for synthesis of derivatives 5c-7c, 8a,b,c-15a,b,c, 16c-26c. i: 100°C, 6h-120h; ii: DMA, 100°C, 24h-168h; iii: toluene, 100°C, 3.5h-96h; iv: DMF, 80°C, 2-48h (8a,b-15a,b); DMA, 100°C, 72-192h (8c-15c).


Results are presented and divided into three groups based on chemical similarities. As far as the antiviral activity is concerned, compounds belonging to N-(4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)amide derivatives (5c-7c) proved to be endowed with selective anti-enterovirus activity, as well as the 4-(4-fluoro-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl) aniline parent (4c), EC50 ranged between 3.8 and 50 µM, as shown in Table 1. These antiviral activity results turned out not far from the previously studied parental compounds either with two methyl groups in positions 5 and 6 (5b-7b) or without any substituent (5a-7a), on the benzotriazole moiety [15Carta, A.; Loriga, G.; Piras, S.; Paglietti, G.; Ferrone, M.; Fermeglia, M.; Pricl, S.; La Colla, P.; Secci, B.; Collu, G.; Loddo, R. Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides. Med. Chem., 2006, 2(6), 577-589.
[http://dx.doi.org/10.2174/1573406410602060577] [PMID: 17105439]
], which were reported in the same Table 1 to better compare the activities. Of the last compounds, we were able to show the compound/Polio helicase complexes, by in silico assays and we provided an insight into the interactions occurring in the active site [15Carta, A.; Loriga, G.; Piras, S.; Paglietti, G.; Ferrone, M.; Fermeglia, M.; Pricl, S.; La Colla, P.; Secci, B.; Collu, G.; Loddo, R. Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides. Med. Chem., 2006, 2(6), 577-589.
[http://dx.doi.org/10.2174/1573406410602060577] [PMID: 17105439]
]. We have also observed that the substitution of the methyl groups with chlorine atoms, in position 5 and 6 on the benzotriazole scaffold (5d-7d), causes a completely loss of activity, with both EC50 and CC50 values higher than 100 µM [16Piras, S.; Sanna, G.; Carta, A.; Corona, P.; Ibba, R.; Loddo, R.; Madeddu, S.; Caria, P.; Aulic, S.; Laurini, E.; Fermeglia, M.; Pricl, S. Dichloro-phenyl-benzotriazoles: A new selective class of human respiratory syncytial virus entry inhibitors. Front Chem., 2019, 7(MAR), 247.
[http://dx.doi.org/10.3389/fchem.2019.00247] [PMID: 31041309]
]. The newly synthesised derivatives with a fluorine atom in position 4 showed an increase in the antiviral activity; they have more widespread activities against CV-B5 and Sb-1 if compared to previously reported derivatives and turned out with lower EC50 values, combined with a low or no cytotoxicity.

Table 1
Cytotoxicity and antiviral activity of derivatives 4a,b,c,d-7a,b,c,d against CV-B5 and Sb-1. Data represent mean values of three independent determinations. Pleconaril was used as a positive control.


As shown in Table 1, the antiviral activity against the CV-B5 and Sb-1 for derivatives 5c-7c, increases with the size of the side chain, with compound 7c being the most active against both viruses.

Moreover, the substitution of the aliphatic side chain with an aromatic moiety on the amide nitrogen (compounds 8a,b,c-15a,b,c) dramatically cancels the antiviral activity (not listed in a table); on the contrary, the corresponding chlorine-derivatives have shown extensive antiviral activity against CV-B5, BVDV, hRSV [16Piras, S.; Sanna, G.; Carta, A.; Corona, P.; Ibba, R.; Loddo, R.; Madeddu, S.; Caria, P.; Aulic, S.; Laurini, E.; Fermeglia, M.; Pricl, S. Dichloro-phenyl-benzotriazoles: A new selective class of human respiratory syncytial virus entry inhibitors. Front Chem., 2019, 7(MAR), 247.
[http://dx.doi.org/10.3389/fchem.2019.00247] [PMID: 31041309]
] and orthohantavirus (HTNV) [25Sanna, G.; Piras, S.; Madeddu, S.; Busonera, B.; Klempa, B.; Corona, P.; Ibba, R.; Murineddu, G.; Carta, A.; Loddo, R. 5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus. Viruses, 2020, 12(1), 122.
[http://dx.doi.org/10.3390/v12010122] [PMID: 31968537]
] with EC50 values ranged between 3 and 27 µM.

Emboldened by the high anti-hRSV activity of 5,6-dichloro-2-phenyl-benzotriazole urea derivatives [16Piras, S.; Sanna, G.; Carta, A.; Corona, P.; Ibba, R.; Loddo, R.; Madeddu, S.; Caria, P.; Aulic, S.; Laurini, E.; Fermeglia, M.; Pricl, S. Dichloro-phenyl-benzotriazoles: A new selective class of human respiratory syncytial virus entry inhibitors. Front Chem., 2019, 7(MAR), 247.
[http://dx.doi.org/10.3389/fchem.2019.00247] [PMID: 31041309]
], we have synthesised and tested a series of ureidic derivatives bearing the fluorine atom in position 4 (16c-26c). Surprisingly, none of the newly synthesised compounds 16c-26c showed antiviral activity against hRSV. On the other hand, they have once again proved to be active against CV-B5 and Sb-1, as shown in Table 2. Further, only derivatives bearing an aliphatic side chain were proved active against the virus replication. The potency increases as the chain length up to a maximum of 4 linear carbon atoms (compound 18c showed an EC50 value of 5.5 µM). Among urea derivatives already published for their antiviral activity against orthohantavirus (16d-18d, 20d-26d) [25Sanna, G.; Piras, S.; Madeddu, S.; Busonera, B.; Klempa, B.; Corona, P.; Ibba, R.; Murineddu, G.; Carta, A.; Loddo, R. 5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus. Viruses, 2020, 12(1), 122.
[http://dx.doi.org/10.3390/v12010122] [PMID: 31968537]
], hRSV (16d-18d, 20d-26d) [16Piras, S.; Sanna, G.; Carta, A.; Corona, P.; Ibba, R.; Loddo, R.; Madeddu, S.; Caria, P.; Aulic, S.; Laurini, E.; Fermeglia, M.; Pricl, S. Dichloro-phenyl-benzotriazoles: A new selective class of human respiratory syncytial virus entry inhibitors. Front Chem., 2019, 7(MAR), 247.
[http://dx.doi.org/10.3389/fchem.2019.00247] [PMID: 31041309]
] and CV-B5 (16a,b-26a,b) [17Piras, S.; Corona, P.; Ibba, R.; Riu, F.; Murineddu, G.; Sanna, G.; Madeddu, S.; Delogu, I.; Loddo, R.; Carta, A. Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)- 1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas. Med. Chem., 2020, 16(5), 677-688.
[http://dx.doi.org/10.2174/1573406416666191226142744] [PMID: 31878859]
], compounds 16d-18d, 20d-26d had turned out completely inactive when tested against CV-B5 and Sb-1, while compounds 16a,b-26a,b were active against CV-B5 and Sb-1 but inactive when tested against hRSV. In this series, as previously seen with benzamide derivative, the insertion of an aromatic moiety on the urea nitrogen leads to total loss of activity. The newly synthesised 4-F urea derivatives showed an additional anti-Sb-1 activity, while none of the previously tested compounds were found to be active.

Table 2
Cytotoxicity and antiviral activity of derivatives 16c-26c against CV-B5 and Sb-1. Data represent mean values of three independent determinations. Pleconaril was used as a positive control.


Table 3
Comparison of the antiviral activity of urea derivatives 16a,b,c-19a,b,c, 16d-18d against CV-B5, Sb-1. Data represent mean values of three independent determinations. Pleconaril was used as a positive control.


The antiviral activity profile of these newly designed and synthesised compounds was compared with others that we previously reported, to extend the SARs analysis. In the series of N-(4-(R-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)alkylamides, the introduction of a fluorine atom in position 4, resulted in a power increase on both viral strains if compared to the parental compounds without any substituent on the benzotriazole scaffold or with methyl groups which were found only slightly active, while derivatives with two chlorine atoms were totally inactive (Table 3). Concerning the series of N-(4-(R-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)-4-aryl-benzamides, the introduction of a functionalized aromatic substituent was brought to a total loss of activity. The only exception was represented by already known derivatives with two chlorine atoms, which were active towards hRSV, CV-B5, BVDV and HNTV. 3-(4-(R-2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
]triazol-2-yl)phenyl)urea derivatives series showing a peculiar trend; only compounds with alkyl chains linked to urea nitrogen were proven active. New derivatives with fluorine atom in position 4 were detected as the best when compared with parental published compounds, both for the EC50 values and for the wider spectrum of activity, since they are also active towards Sb-1. The replacement with two chlorine atoms completely changed the activity spectrum as they were found inactive against enteroviruses, but very active when tested against hRSV and HTNV.

CONCLUSION

Presently, we can conclude that N-(4-(2H-benzo[d] [1Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
-3Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
] triazol-2-yl)phenyl-R-amide is a good chemical scaffold for the development of new antiviral molecules. To gain the best anti-enterovirus profile, the substituent on benzotriazole moiety should be small as a fluorine atom, and in position 4; the substitution on the amide nitrogen must be with an alkyl short chain. The replacement of the amide group with alkyl-urea groups was beneficial for the antiviral activity. On the contrary, in both series (amide derivatives and urea compounds), the presence of aromatic substituents caused a total loss of activity. According to the high selectivity, lack of cytotoxicity and interesting potency, we can select 7c, 17c and 18c as lead compounds. Future aims will be to extend the screen and to involve in our research additional enteroviruses with enormous medical impacts such as enterovirus A71 and enterovirus D68.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

Not applicable.

HUMAN AND ANIMAL RIGHTS

No animals/humans were used for studies that are the basis of this research.

CONSENT FOR PUBLICATION

Not applicable.

AVAILABILITY OF DATA AND MATERIALS

Not applicable.

FUNDING

The study is financially supported by the “University of Sassari, Italy, Fondo di Ateneo per la ricerca 2019 Grant: FAR2019CORON”, and “Regione Autonoma della Sardegna, Italy, Grant: RASSR01499”, and the “MIUR (Italy), PRIN 2015, Grant: 2015C7PCYZ.

CONFLICT OF INTEREST

The author declares no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

Authors acknowledge the generous financial support from the University of Sassari, Italy, Regione Autonoma della Sardegna, Italy, and MIUR (Ministero dell'Istruzione, dell'Università e della Ricerca), Italy.

SUPPLEMENTARY MATERIAL

Supplementary material is available on the publishers website along with the published article.


Download File


REFERENCES

[1] Kale, R.R.; Prasad, V.; Mohapatra, P.P.; Tiwari, V.K. Recent developments in benzotriazole methodology for construction of pharmacologically important heterocyclic skeletons. Monatshefte für Chemie - Chem. Mon., 2010, 141(11), 1159-1182.
[http://dx.doi.org/10.1007/s00706-010-0378-1]
[2] Katritzky, A.R.; Henderson, S.A.; Yang, B. Applications of benzotriazole methodology in heterocycle ring synthesis and substituent introduction and modification. J. Heterocycl. Chem., 1998, 35(5), 1123-1159.
[http://dx.doi.org/10.1002/jhet.5570350511]
[3] Katritzky, A.R.; Lan, X.; Yang, J.Z.; Denisko, O.V. Properties and synthetic utility of n-substituted benzotriazoles. Chem. Rev., 1998, 98(2), 409-548.
[http://dx.doi.org/10.1021/cr941170v] [PMID: 11848906]
[4] Katritzky, A.R.; Rogovoy, B.V. Benzotriazole: An ideal synthetic auxiliary. Chemistry, 2003, 9(19), 4586-4593.
[http://dx.doi.org/10.1002/chem.200304990] [PMID: 14566863]
[5] Wang, X.; Liu, Y. Y. Z. Elimination of benzotriazolyl group in n-(α-benzotriazol-1-ylalkyl)amides and n-(α-benzotriazol-1-ylalkyl)sulfonamides: Their self-coupling and cross-coupling reactions with carbonyl compounds. Tetrahedron, 2003, 59, 8257-8263.
[http://dx.doi.org/10.1016/j.tet.2003.08.039]
[6] Briguglio, I.; Piras, S.; Corona, P.; Gavini, E.; Nieddu, M.; Boatto, G.; Carta, A. Benzotriazole: An overview on its versatile biological behavior. Eur. J. Med. Chem., 2015, 97(1), 612-648.
[http://dx.doi.org/10.1016/j.ejmech.2014.09.089] [PMID: 25293580]
[7] Christou, L. The global burden of bacterial and viral zoonotic infections. Clinical Microbiology and Infection, 2011, 17(3), 326-30.
[8] Wolfe, N. D.; Dunavan, C. P.; Diamond, J. Origins of major human infectious diseases. Nature, 2007, 279-283. Nature Publishing Group May 17
[9] Grais, R. F.; Strebel, P.; Mala, P.; Watson, J.; Nandy, R.; Gayer, M. Measles vaccination in humanitarian emergencies: A review of recent practice. Conflict Health. BioMed Central, 2011, 21.
[10] Coronavirus, Avaliable at: https://www.who.int/health-topics/corona virus#tab=tab_1
[11] Zhang, H-Z.; Gan, L-L.; Wang, H.; Zhou, C-H. New progress in azole compounds as antimicrobial agents. Mini Rev. Med. Chem., 2017, 17(2), 122-166.
[http://dx.doi.org/10.2174/1389557516666160630120725] [PMID: 27484625]
[12] Carta, A.; Sanna, G.; Briguglio, I.; Madeddu, S.; Vitale, G.; Piras, S.; Corona, P.; Peana, A.T.; Laurini, E.; Fermeglia, M.; Pricl, S.; Serra, A.; Carta, E.; Loddo, R.; Giliberti, G. Quinoxaline derivatives as new inhibitors of coxsackievirus B5. Eur. J. Med. Chem., 2018, 145, 559-569.
[http://dx.doi.org/10.1016/j.ejmech.2017.12.083] [PMID: 29339251]
[13] Loddo, R.; Briguglio, I.; Corona, P.; Piras, S.; Loriga, M.; Paglietti, G.; Carta, A.; Sanna, G.; Giliberti, G.; Ibba, C.; Farci, P.; La Colla, P. Synthesis and antiviral activity of new phenylimidazopyridines and N-benzylidenequinolinamines derived by molecular simplification of phenylimidazo [4,5-g]quinolines. Eur. J. Med. Chem., 2014, 84, 8-16.
[http://dx.doi.org/10.1016/j.ejmech.2014.07.011] [PMID: 25014745]
[14] Sanna, G.; Madeddu, S.; Giliberti, G.; Piras, S.; Struga, M.; Wrzosek, M.; Kubiak-Tomaszewska, G.; Koziol, A.E.; Savchenko, O.; Lis, T.; Stefanska, J.; Tomaszewski, P.; Skrzycki, M.; Szulczyk, D. Synthesis and biological evaluation of novel indole-derived thioureas. Molecules, 2018, 23(10), 2554.
[http://dx.doi.org/10.3390/molecules23102554] [PMID: 30301264]
[15] Carta, A.; Loriga, G.; Piras, S.; Paglietti, G.; Ferrone, M.; Fermeglia, M.; Pricl, S.; La Colla, P.; Secci, B.; Collu, G.; Loddo, R. Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides. Med. Chem., 2006, 2(6), 577-589.
[http://dx.doi.org/10.2174/1573406410602060577] [PMID: 17105439]
[16] Piras, S.; Sanna, G.; Carta, A.; Corona, P.; Ibba, R.; Loddo, R.; Madeddu, S.; Caria, P.; Aulic, S.; Laurini, E.; Fermeglia, M.; Pricl, S. Dichloro-phenyl-benzotriazoles: A new selective class of human respiratory syncytial virus entry inhibitors. Front Chem., 2019, 7(MAR), 247.
[http://dx.doi.org/10.3389/fchem.2019.00247] [PMID: 31041309]
[17] Piras, S.; Corona, P.; Ibba, R.; Riu, F.; Murineddu, G.; Sanna, G.; Madeddu, S.; Delogu, I.; Loddo, R.; Carta, A. Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)- 1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas. Med. Chem., 2020, 16(5), 677-688.
[http://dx.doi.org/10.2174/1573406416666191226142744] [PMID: 31878859]
[18] Briguglio, I.; Loddo, R.; Laurini, E.; Fermeglia, M.; Piras, S.; Corona, P.; Giunchedi, P.; Gavini, E.; Sanna, G.; Giliberti, G.; Ibba, C.; Farci, P.; La Colla, P.; Pricl, S.; Carta, A. Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives. Eur. J. Med. Chem., 2015, 105, 63-79.
[http://dx.doi.org/10.1016/j.ejmech.2015.10.002] [PMID: 26479028]
[19] Carta, A.; Briguglio, I.; Piras, S.; Corona, P.; Ibba, R.; Laurini, E.; Fermeglia, M.; Pricl, S.; Desideri, N.; Atzori, E.M.M.; La Colla, P.; Collu, G.; Delogu, I.; Loddo, R. A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems. Eur. J. Med. Chem., 2016, 117, 321-334.
[http://dx.doi.org/10.1016/j.ejmech.2016.03.080] [PMID: 27161176]
[20] Kirk, K.L.; Cohen, L.A. The synthesis of some fluoronitrobenzimidazoles and their reactivities toward peptide nucleophiles. J. Org. Chem., 1969, 34(2), 384-389.
[http://dx.doi.org/10.1021/jo01254a027] [PMID: 5786166]
[21] Liedholm, B.; Nyberg, I.; Svanholm, U.; Duffield, A.M.; Balaban, A.T.; Craig, J.C. Copper(I) catalysed replacement of bromine by chloride ion in halonitrobenzenes. Acta Chem. Scand., 1969, 23, 3175-3186.
[http://dx.doi.org/10.3891/acta.chem.scand.23-3175]
[22] Pauwels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdewijn, P.; Desmyter, J.; De Clercq, E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods, 1988, 20(4), 309-321.
[http://dx.doi.org/10.1016/0166-0934(88)90134-6] [PMID: 2460479]
[23] Carta, A.; Bua, A.; Corona, P.; Piras, S.; Briguglio, I.; Molicotti, P.; Zanetti, S.; Laurini, E.; Aulic, S.; Fermeglia, M.; Pricl, S. Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase. Eur. J. Med. Chem., 2019, 161, 399-415.
[http://dx.doi.org/10.1016/j.ejmech.2018.10.031] [PMID: 30384044]
[24] Carta, A.; Sanna, P.; Paglietti, G.; Sparatore, F. 13C-NMR as useful tool for unambiguous identification of ring substituted n1(2)(3)-alkylbenzotriazole isomers. Heterocycles, 2001, 55(6), 1133.
[http://dx.doi.org/10.3987/COM-01-9189]
[25] Sanna, G.; Piras, S.; Madeddu, S.; Busonera, B.; Klempa, B.; Corona, P.; Ibba, R.; Murineddu, G.; Carta, A.; Loddo, R. 5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus. Viruses, 2020, 12(1), 122.
[http://dx.doi.org/10.3390/v12010122] [PMID: 31968537]
Track Your Manuscript:


Endorsements



"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."


Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."


Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."


Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."


Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."


Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."


Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."


Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."


J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."


Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."


Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."


Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."


Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."


Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."


M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."


Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."


Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."


Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."


Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."


Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."


Jih Ru Hwu
(National Central University, Taiwan)


Browse Contents



Table of Contents


Webmaster Contact: info@benthamopen.net
Copyright © 2021 Bentham Open